<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92110</article-id><article-id pub-id-type="doi">10.7554/eLife.92110</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92110.4</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Plant Biology</subject></subj-group></article-categories><title-group><article-title>Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mühlenbeck</surname><given-names>Henning</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Tsutsui</surname><given-names>Yuko</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lemmon</surname><given-names>Mark A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Bender</surname><given-names>Kyle W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1805-8097</contrib-id><email>kyle.bender@botinst.uzh.ch</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zipfel</surname><given-names>Cyril</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4935-8583</contrib-id><email>cyril.zipfel@botinst.uzh.ch</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>Institute of Plant and Microbial Biology, Zürich-Basel Plant Science Center, University of Zürich</institution></institution-wrap><addr-line><named-content content-type="city">Zürich</named-content></addr-line><country>Switzerland</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Department of Pharmacology, Yale University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale Cancer Biology Institute, Yale University West Campus</institution></institution-wrap><addr-line><named-content content-type="city">West Haven</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0062dz060</institution-id><institution>The Sainsbury Laboratory, University of East Anglia, Norwich Research Park</institution></institution-wrap><addr-line><named-content content-type="city">Norwich</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University</institution></institution-wrap><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>19</day><month>07</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP92110</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-08-23"><day>23</day><month>08</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-08-25"><day>25</day><month>08</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.23.554490"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-11-23"><day>23</day><month>11</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92110.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-05-01"><day>01</day><month>05</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92110.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-06-13"><day>13</day><month>06</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92110.3"/></event></pub-history><permissions><copyright-statement>© 2023, Mühlenbeck et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Mühlenbeck et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-92110-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-92110-figures-v1.pdf"/><abstract><p>Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non-catalytic signaling mechanisms of protein kinase domains have been described in metazoans, but information is scarce for plants. Recently, a non-catalytic function was reported for the leucine-rich repeat (LRR)-RK subfamily XIIa member EFR (elongation factor Tu receptor) and phosphorylation-dependent conformational changes were proposed to regulate signaling of RKs with non-RD kinase domains. Here, using EFR as a model, we describe a non-catalytic activation mechanism for LRR-RKs with non-RD kinase domains. EFR is an active kinase, but a kinase-dead variant retains the ability to enhance catalytic activity of its co-receptor kinase BAK1/SERK3 (brassinosteroid insensitive 1-associated kinase 1/somatic embryogenesis receptor kinase 3). Applying hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis and designing homology-based intragenic suppressor mutations, we provide evidence that the EFR kinase domain must adopt its active conformation in order to activate BAK1 allosterically, likely by supporting αC-helix positioning in BAK1. Our results suggest a conformational toggle model for signaling, in which BAK1 first phosphorylates EFR in the activation loop to stabilize its active conformation, allowing EFR in turn to allosterically activate BAK1.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>receptor kinase</kwd><kwd>allostery</kwd><kwd>protein kinase</kwd><kwd>phosphorylation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>A. thaliana</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>31003A_182625</award-id><principal-award-recipient><name><surname>Zipfel</surname><given-names>Cyril</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100014013</institution-id><institution>UK Research and Innovation</institution></institution-wrap></funding-source><award-id>BB/S004734/1</award-id><principal-award-recipient><name><surname>Zipfel</surname><given-names>Cyril</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35-GM122485</award-id><principal-award-recipient><name><surname>Lemmon</surname><given-names>Mark A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Structure-function analysis reveals an allosteric mechanism activating a plant immune receptor kinase complex.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Plants and metazoans respond to extracellular signals through different sets of plasma membrane receptors. Whereas the G-protein coupled receptor family expanded in metazoans, the receptor kinase (RK) and receptor protein (RP) families expanded in plants (<xref ref-type="bibr" rid="bib62">Shiu and Bleecker, 2003</xref>; <xref ref-type="bibr" rid="bib61">Shiu and Bleecker, 2001</xref>; <xref ref-type="bibr" rid="bib66">Trusov and Botella, 2016</xref>). Plant RKs resemble metazoan receptor tyrosine kinases (RTKs) in their organization, containing an extracellular ligand-sensing domain that is coupled to an intracellular kinase domain by a single-pass transmembrane helix (<xref ref-type="bibr" rid="bib17">Hohmann et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Lemmon and Schlessinger, 2010</xref>). In contrast to RTKs, however, the intracellular kinase domain of plant RKs is a serine/threonine kinase domain most closely related to interleukin-1 receptor associated kinases (IRAKs)/Pelle kinases (<xref ref-type="bibr" rid="bib62">Shiu and Bleecker, 2003</xref>; <xref ref-type="bibr" rid="bib61">Shiu and Bleecker, 2001</xref>) – although dual-specificity kinase activity has been reported in some cases (<xref ref-type="bibr" rid="bib32">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Luo et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Macho et al., 2014</xref>; <xref ref-type="bibr" rid="bib46">Oh et al., 2009</xref>; <xref ref-type="bibr" rid="bib49">Perraki et al., 2018</xref>).</p><p>The leucine-rich repeat (LRR)-RKs are the most extensively studied sub-family of <italic>Arabidopsis thaliana</italic> (hereafter <italic>Arabidopsis</italic>) RKs. They primarily sense peptide ligands that regulate growth and development, or molecular patterns that are released during damage or microbial infection (<xref ref-type="bibr" rid="bib8">Couto and Zipfel, 2016</xref>). Ligand-binding LRR-RKs have long ectodomains (&gt;20 LRRs), and recruit short LRR ectodomain-containing co-receptor kinases (coRKs) upon ligand perception (<xref ref-type="bibr" rid="bib4">Bender and Zipfel, 2023</xref>; <xref ref-type="bibr" rid="bib17">Hohmann et al., 2017</xref>), most of which belong to the SERK (somatic embryogenesis receptor kinase) family. One of the most well characterized LRR-RKs is BRI1 (brassinosteroid insensitive 1), which recruits the coRKs SERK1 and SERK3/BAK1 (BRI1-associated kinase 1) upon brassinosteroid (BR) perception (<xref ref-type="bibr" rid="bib1">Albrecht et al., 2008</xref>; <xref ref-type="bibr" rid="bib16">He et al., 2000</xref>; <xref ref-type="bibr" rid="bib18">Hothorn et al., 2011</xref>; <xref ref-type="bibr" rid="bib45">Nam and Li, 2002</xref>; <xref ref-type="bibr" rid="bib54">Santiago et al., 2013</xref>). After ligand perception, the intracellular kinase domains of BRI1 and BAK1 reciprocally trans-phosphorylate each other in their activation loops (<xref ref-type="bibr" rid="bib17">Hohmann et al., 2017</xref>), and BAK1 then phosphorylates BRI1 in its juxtamembrane segment and C-tail to propagate BR signaling (<xref ref-type="bibr" rid="bib69">Wang et al., 2008</xref>; <xref ref-type="bibr" rid="bib68">Wang et al., 2005</xref>). BRI1 exemplifies a set of BAK1-dependent LRR-RKs that have RD-type intracellular kinase domains and require their catalytic activity to signal (<xref ref-type="bibr" rid="bib5">Cao et al., 2013</xref>; <xref ref-type="bibr" rid="bib25">Kosentka et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Taylor et al., 2016</xref>). Other LRR-RKs such as EFR (elongation factor Tu receptor) instead have non-RD intracellular kinases, and are thought not to <italic>trans-</italic>phosphorylate their associated coRK following ligand perception (<xref ref-type="bibr" rid="bib57">Schwessinger et al., 2011</xref>). Moreover, kinase inactive mutants of EFR (D849N or K851E) retain signaling function, a result that challenges the generality of the reciprocal trans-phosphorylation model (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>).</p><p>EFR perceives the pathogen-associated molecular pattern (PAMP) elongation factor Tu, or its active peptide epitope elf18 (<xref ref-type="bibr" rid="bib76">Zipfel et al., 2006</xref>). PAMP perception triggers heterodimerization with the coRK BAK1, resulting in phosphorylation of the EFR intracellular kinase domain (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>; <xref ref-type="bibr" rid="bib53">Roux et al., 2011</xref>; <xref ref-type="bibr" rid="bib56">Schulze et al., 2010</xref>; <xref ref-type="bibr" rid="bib57">Schwessinger et al., 2011</xref>). The signal is subsequently relayed to the cytoplasmic kinases BIK1 (botrytis-induced kinase 1) and PBL1 (PBS1-like 1) (<xref ref-type="bibr" rid="bib29">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Lu et al., 2010</xref>; <xref ref-type="bibr" rid="bib51">Ranf et al., 2014</xref>). The resulting immune signaling activation elicits a battery of cellular responses, including an apoplastic oxidative burst (hereafter oxidative burst), Ca<sup>2+</sup>-influx, callose deposition, MAPK (mitogen activated protein kinase) activation, and transcriptional reprogramming (<xref ref-type="bibr" rid="bib10">DeFalco and Zipfel, 2021</xref>).</p><p>Initial studies in vitro identified phosphorylation sites in EFR that result either from auto-phosphorylation or from trans-phosphorylation by BAK1 (<xref ref-type="bibr" rid="bib70">Wang et al., 2014</xref>). More recently, in vivo phosphorylation sites on EFR were identified by immunoprecipitating EFR-GFP from elf18-treated seedlings (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>). One was a serine (S888) in the activation loop (A-loop), at which phosphorylation was consistently observed in vitro and in vivo (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>; <xref ref-type="bibr" rid="bib70">Wang et al., 2014</xref>). Despite the non-RD nature of EFR, and its ability to signal independently of catalytic activity, ligand-inducible phosphorylation in the A-loop (S887/S888) surprisingly proved indispensable for signaling (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>). Furthermore, a functionally important tyrosine in EFR (Y836) – conserved in subdomain VIa of many eukaryotic protein kinases (<xref ref-type="bibr" rid="bib27">Lai et al., 2016</xref>; <xref ref-type="bibr" rid="bib34">Luo et al., 2020</xref>; <xref ref-type="bibr" rid="bib49">Perraki et al., 2018</xref>) – was found to be phosphorylated after ligand treatment in vivo (<xref ref-type="bibr" rid="bib36">Macho et al., 2014</xref>). A phospho-ablative Y836F mutation in EFR blocks immune signaling and resistance against the phytopathogenic bacterium <italic>Pseudomonas syringae</italic> (<xref ref-type="bibr" rid="bib36">Macho et al., 2014</xref>). Thus, although EFR function does not require its catalytic activity, both A-loop phosphorylation and phosphorylation of the VIa subdomain tyrosine (VIa-Tyr) appear to be crucial. The mechanistic importance of these phosphorylation events remains poorly understood, but we hypothesized that they switch the EFR kinase domain into an active-like conformation that allosterically activates BAK1 in the EFR-BAK1 complex through a mechanism similar to that described for pseudokinases (<xref ref-type="bibr" rid="bib35">Mace and Murphy, 2021</xref>; <xref ref-type="bibr" rid="bib60">Sheetz and Lemmon, 2022</xref>) – ultimately promoting BAK1’s activity toward its substrate BIK1.</p><p>Here, we tested the hypothesis that EFR is an allosteric regulator of BAK1 using a range of different approaches. Our in vitro studies revealed that forcing dimerization of the EFR and BAK1 intracellular domains allosterically enhances BAK1 activity. Using a homology-guided approach, we designed mutations to stabilize the active-like conformation of the EFR kinase domain and found that they restore functionality of EFR variants that cannot be phosphorylated in the A-loop (EFR<sup>SSAA</sup>) or at Y836 (EFR<sup>Y836F</sup>). We also used hydrogen-deuterium exchange mass spectrometry (HDX-MS) to analyze conformational dynamics, revealing that the Y836F mutation hampers the ability of the EFR kinase domain to adopt an active-like conformation. Collectively, our findings argue that the active conformation of the EFR kinase domain is required for allosteric activation of the BAK1 kinase domain. Finally, we present evidence suggesting that EFR activates BAK1 allosterically by supporting αC-helix positioning in BAK1.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The EFR intracellular domain allosterically activates BAK1 in vitro</title><p>To test the hypothesis that EFR enhances BAK1 catalytic activity allosterically, we used rapamycin (Rap)-induced dimerization (RiD) to induce a complex between the isolated EFR and BAK1 intracellular domains (<xref ref-type="bibr" rid="bib2">Banaszynski et al., 2005</xref>; <xref ref-type="bibr" rid="bib24">Kim et al., 2021</xref>). The RiD system was previously applied in planta, maintaining membrane-association by N-terminal myristoylation (<xref ref-type="bibr" rid="bib24">Kim et al., 2021</xref>). For our in vitro experiments, the myristoylation sites were excluded to facilitate the purification of recombinant protein. We tested two LRR-RKs: EFR and BRI1, fusing GFP C-terminally and FKBP (FK506 binding protein) N-terminally to their intracellular domains. BAK1 instead was N-terminally tagged with FRB (FKBP-Rap-binding). We first confirmed that adding Rap induced formation of FKBP-EFR/FRB-BAK1 dimers in size exclusion chromatography experiments (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We then assessed the effect of inducing RK/coRK kinase complex formation on their ability to phosphorylate BIK1<sup>D202N</sup>. BIK1 was chosen as it is a reported substrate of both, EFR/BAK1 and BRI1/BAK1 complexes (<xref ref-type="bibr" rid="bib30">Lin et al., 2013</xref>). Rap addition increased BIK1<sup>D202N</sup> phosphorylation when the BRI1 or EFR kinase domains were dimerized with BAK1 (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). Kinase-dead variants with the catalytic residue (HRD-aspartate) replaced by asparagine (EFR<sup>D849N</sup> and BRI1<sup>D1009N</sup>), had distinct effects. BRI1<sup>D1009N</sup> failed to enhance BIK1 phosphorylation substantially, whereas EFR<sup>D849N</sup> retained some ability to do so (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). The same trend was observed for phosphorylation of the BAK1 kinase domain itself, indicating that EFR also enhances BAK1 autophosphorylation activity (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>EFR facilitates BIK1 trans-phosphorylation by BAK1 non-catalytically.</title><p>The kinase domains of coRK BAK1 and the RKs BRI1 and EFR were tagged with RiD domains and purified from <italic>E. coli</italic> λPP cells. (<bold>A</bold>) Recombinantly expressed RiD-tagged kinase domains were mixed together at equimolar ratios (2 µM), with or without addition of 10 µM Rap as well as 10 mM MgCl<sub>2</sub> and 1 mM AMP-PNP. (<bold>B</bold>) RK and coRK were mixed at an equimolar ratio at 50 nM, kinase-dead BIK1<sup>D202N</sup> substrate was added at 500 nM. Reactions were carried out at RT for 10 min with 0.5 μCi [γ-³²P]ATP, 100 μM ATP and 2.5 mM each of MgCl<sub>2</sub> and MnCl<sub>2</sub>. Addition of 1 μM Rap enhanced transphosphorylation of BIK1 by EFR and BRI1. Kinase-dead BRI1 failed to enhance BIK1 transphosphorylation, but kinase-dead EFR retained some ability to do so. A similar trend was observed for (auto)phosphorylation of BAK1 itself. (<bold>C</bold>) Quantification of band intensities over three independent experiments of which a representative is shown in B.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw data for gel images in <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Raw data for autoradiography in <xref ref-type="fig" rid="fig1">Figure 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>EFR<sup>Y836F</sup> compromises ligand-induced receptor complex activation.</title><p>Two-week old seedlings were mock treated or treated with 1 µM elf18 for 10 min. Immunoprecipitation was then performed with anti-GFP, and the resulting immunoprecipitates probed for BAK1 S612 phosphorylation. Phosphorylated BAK1 was found to co-immunoprecipitate with WT EFR-GFP but hardly with EFR<sup>Y836F</sup>-GFP, indicating ligand-induced receptor complex activation.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Raw data for immunoblots in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig1-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig1-figsupp1-v1.tif"/></fig></fig-group><p>The increased BIK1 trans-phosphorylation observed in these in vitro RiD experiments could arise either from direct enhancement of BAK1 activity by the RK kinase domain or from more efficient BIK1<sup>D202N</sup> recruitment to the dimerized RK/coRK complex. We found that BIK1<sup>D202N</sup> did not co-elute with the EFR-BAK1 complex in size exclusion studies, indicating that stable EFR/BAK1/BIK1 trimers do not form in vitro (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Our findings therefore support the hypothesis that EFR increases BIK1 phosphorylation by allosterically activating the BAK1 kinase domain. Although EFR’s catalytic activity is dispensable for this effect – and for immune signaling – EFR must be phosphorylated at S887/S888 in the A-loop and Y836 to signal in vivo (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Macho et al., 2014</xref>). The phospho-ablative EFR A-loop mutant EFR<sup>SSAA</sup> fails to activate the RK/coRK complex, as ligand-induced phosphorylation of BAK1 S612 – a mark for active BAK1-containing receptor complexes (<xref ref-type="bibr" rid="bib49">Perraki et al., 2018</xref>) – is obstructed despite retaining the ability to associate with BAK1 in a ligand-dependent manner (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>). To test whether the requirement for Y836 phosphorylation is similar, we immunoprecipitated EFR-GFP and EFR<sup>Y836F</sup>-GFP from mock- or elf18-treated seedlings and probed co-immunoprecipitated BAK1 for S612 phosphorylation. EFR<sup>Y836F</sup> also obstructed the induction of BAK1 S612 phosphorylation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), indicating that EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> impair receptor complex activation.</p></sec><sec id="s2-2"><title>EFR VIa-Tyr mutation affects dynamics of regulatory kinase subdomains</title><p>Y836 in EFR corresponds in sequence and structural alignments with Y156 in the canonical kinase PKA (protein kinase A) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplements 1</xref> and <xref ref-type="fig" rid="fig2s2">2A</xref>), which is conserved in many protein kinases. We therefore speculated that Y836 may function as a pivot for key movements of the regulatory αC-helix, controlling conformational toggling of inactive/active transitions as described for its PKA counterpart (<xref ref-type="bibr" rid="bib67">Tsigelny et al., 1999</xref>). To test whether an EFR Y836F mutation in EFR interferes with assembly of the active-like EFR kinase conformation we used HDX-MS. Plotting differential HDX (Δ%EX) between unphosphorylated EFR and EFR<sup>Y836F</sup> (aa684-1031) identifies one region that is stabilized in EFR<sup>Y836F</sup> compared to wild-type and two that are destabilized (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). The region stabilized in EFR<sup>Y836F</sup> contains the N-terminal part of the A-loop, implying that this region makes more extensive contacts with the kinase core than in the unphosphorylated wild-type kinase domain. Alternatively, the decreased deuterium uptake in the EFR<sup>Y836F</sup> A-loop could arise from stabilization of a short A-loop α-helix, as seen in the inactive conformation of many kinases (such as in epidermal growth factor receptor). The two regions that become more structurally flexible in EFR<sup>Y836F</sup> include the β3-αC loop and the catalytic loop plus C-terminal end of the αE-helix – where Y836 is located (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). Because these two regions are both important for conformational switching, the HDX-MS results suggest that Y836 is important in regulating kinase domain allosteric transitions. Consistent with this, crystal structures as well as AlphaFold2 models of active kinase conformations (<xref ref-type="bibr" rid="bib13">Faezov and Dunbrack, 2023</xref>) suggest that the side-chain of this tyrosine forms hydrogen-bonds (H-bond) with the αC-β4 loop backbone to establish an inter-lobe connection (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Loss of this inter-lobe connection may underlie the observed alterations in EFR<sup>Y836F</sup> conformational dynamics in EFR<sup>Y836F</sup>, resulting from inaccessibility of the active-like conformation.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> impair the active kinase conformation, which is required for signaling function.</title><p>(<bold>A</bold>) (left) HDX-MS results for unphosphorylated EFR and EFR<sup>Y836F</sup> protein. The difference in percent H/D exchange in wild type EFR and EFR<sup>Y836F</sup> is expressed as the Δ%EX (wild type EFR – EFR<sup>Y836F</sup>), with the positive and negative Δ%EX indicating more stabilized and destabilized regions in EFR<sup>Y836F</sup>, respectively, compared to wild-type EFR. The Δ%EX values at different labeling time points are shown as colored lines, as indicated in the figure. The horizontal dotted black lines indicate the 98% confidence interval for the Δ%EX data (±7.18%, corresponding to ±0.4 Da difference between wild type and Y836F percent exchange) calculated as described previously (<xref ref-type="bibr" rid="bib19">Houde et al., 2011</xref>). Regions with Δ%EX values that exceed this confidence limit are indicated as colored bars in the figure, including the β3-αC loop (orange), the catalytic loop plus part of αE (purple), and the A-loop (blue). These regions are colored in the AlphaFold2-derived model of the EFR kinase domain shown at right, in which Y836 is shown as a purple sphere. All data are the average of three independent biological repeats (n=3) with three technical repeat experiments each. A summary of the HDX-MS analysis is presented in <xref ref-type="table" rid="table3">Table 3</xref>. (<bold>B</bold>) HDX-MS analysis of representative peptides from regions with significantly different HD exchange. Frames are color-coded according to regions in A. Amino acid range of the peptides in full length EFR are indicated in the top left corner and the sequence below. (<bold>C, D</bold>) Secondary site mutation EFR F761[H/M] partially restores function of EFR<sup>Y836F</sup> (<bold>C</bold>) and EFR<sup>SSAA</sup> (<bold>D</bold>). Full length EFR and its variants were expressed transiently in <italic>N. benthamiana</italic> and their function was tested in an oxidative burst assay. EFR F761H partially restored oxidative bursts of EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup>. Outliers are in indicated by asterisk in addition to the outlier itself and are included in statistical analysis; Statistical test: Kruskal-Wallis test (p&lt;2.2*10<sup>–16</sup> in C, p=1.163*10<sup>–7</sup> in D), Dunn’s post-hoc test with Benjamin-Hochberg correction (p ≤ 0.05) Groups with like lowercase letter designations are not statistically different.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>VIa-Tyr forms H-bonds with the αC-β4 loop in various predicted and solved structures.</title><p>Solved structures were retrieved from PDB. AlphaFold2 models for kinases in their active conformation were retrieved from <xref ref-type="bibr" rid="bib13">Faezov and Dunbrack, 2023</xref>. BAK1 and EFR models were predicted by AlphaFold2, using the complete intracellular domain. H-bonds were predicted in ChimeraX and distances are indicated.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Rational design of activating mutations in EFR and screen for functional recovery of EFR<sup>Y836F</sup>.</title><p>(<bold>A</bold>) Alignments of EFR with human kinases containing oncogenic, kinase activating mutations that stabilize the αC-helix-in active-like conformation (described in <xref ref-type="bibr" rid="bib14">Foster et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Hu et al., 2015</xref>). Homologous sites in EFR are indicated by arrows with the residue number. (<bold>B</bold>) Structural model of the EFR kinase domain from AlphaFold2 with homologous sites identified in the sequence alignment from A highlighted in teal (missense mutation) or red (deletion). EFR Y836 at the C-terminal end of the αE-helix is colored purple. (<bold>C</bold>) Screening of the homology-based putatively activating EFR mutations for restoration of EFR<sup>Y836F</sup> function in <italic>N. benthamiana</italic>. All putative activating mutations were functional at WT-like level except EFR<sup>ΔNLLKH</sup>. Only EFR<sup>F761[H/M]</sup> could functionally recover EFR<sup>Y836F</sup> as the oxidative burst was partially restored. (<bold>D</bold>) EFR<sup>L873E</sup> showed a WT-like oxidative burst but EFR<sup>L873E/Y836F</sup> did not restore the oxidative burst. Outliers are in indicated by asterisk in addition to the outlier itself and are included in statistical analysis; Statistical test: Kruskal-Wallis test (p=9.319*10<sup>–6</sup> in C, p=0.01242 in D), Dunn’s post-hoc test with Benjamin-Hochberg correction (p ≤ 0.05) Groups with like lowercase letter designations are not statistically different.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>EFR A-loop phosphorylation sites may coordinate with basic residues from the β3-αC loop and αC-helix.</title><p>(<bold>A</bold>) In PKA (1ATP), the A-loop phosphorylation on T197 coordinates with H87 from the αC-helix. (<bold>B</bold>) In EFR (AlphaFold2 (AF2) model), there are two basic residues extending downwards from β3-αC loop (H748) and αC-helix (K752) that may coordinate with A-loop phosphorylation on S887 or S888.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig2-figsupp3-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Kinase activating mutations restore partial function of EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup></title><p>To build on these results, we next sought to rescue the active-like kinase conformation of EFR<sup>Y836F</sup> by introducing activating mutations. Kinase activating mutations are well known in human disease, and cause different malignancies (<xref ref-type="bibr" rid="bib14">Foster et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Hu et al., 2015</xref>). Because the HDX-MS data indicated a destabilized αC-helix, we were specifically interested in activating mutations thought to stabilize the kinase αC-helix in a ‘swung-in’ state, with the goal of making homologous changes in EFR. Such mutations were systematically identified in BRAF/CRAF by searching oncogenes using phenylalanine substitutions (<xref ref-type="bibr" rid="bib21">Hu et al., 2015</xref>). We exploited these oncogenic BRAF mutations for homology-based design of putative activating EFR mutations at corresponding positions that could function as intragenic suppressors of EFR<sup>Y836F</sup> (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A and B</xref>). Since EFR already carries a phenylalanine at the position corresponding to L505 in BRAF, we generated EFR<sup>F761[H/M]</sup> to resemble mutations known to potently activate BRAF (<xref ref-type="bibr" rid="bib21">Hu et al., 2015</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Homology-based design of putative intragenic suppressor mutations for EFR.</title><p>The list contains the residue number of EFR and the analogous oncogenic mutation in BRAF, as well as a short description of the mode of action of the oncogenic mutation. See <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref> for structural locations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">EFR mutation</th><th align="left" valign="bottom">Analogous oncogenic mutation</th><th align="left" valign="bottom">Mode of action</th><th align="left" valign="bottom">Source</th></tr></thead><tbody><tr><td align="left" valign="bottom">L743F</td><td align="left" valign="bottom">BRAF L485F</td><td align="left" valign="bottom">Extended hydrophobic interaction network along the αC-helix</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Hu et al., 2015</xref></td></tr><tr><td align="left" valign="bottom">F761[H/M]</td><td align="left" valign="bottom">BRAF L505[F/H/M]</td><td align="left" valign="bottom">Enforcement of hydrophobic interactions in the regulatory spine</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Hu et al., 2015</xref></td></tr><tr><td align="left" valign="bottom">ΔNLLKH</td><td align="left" valign="bottom">BRAF ΔNVTAP</td><td align="left" valign="bottom">Shortening of β3-αC-helix loop, pulling ‘in’ the αC-helix</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Foster et al., 2016</xref></td></tr><tr><td align="left" valign="bottom">L873E</td><td align="left" valign="bottom">BRAF V600E</td><td align="left" valign="bottom">Upward bending of C-terminal αC-helix end</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Hu et al., 2015</xref></td></tr></tbody></table></table-wrap><p>The putative activating mutations were introduced into either EFR<sup>WT</sup> or EFR<sup>Y836F</sup> and transiently expressed in <italic>Nicotiana benthamiana</italic> to test receptor function. As expected, heterologous expression of EFR<sup>WT</sup> but not of EFR<sup>Y836F</sup> conferred elf18 sensitivity (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>). When introduced on their own into EFR<sup>WT</sup>, the single mutations L743F, F761[HM], and L873E were all consistent with wild-type EFR function, supporting an elf18-induced oxidative burst, except for the ΔNLLKH deletion (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>). Intriguingly, the F761[H/M] mutations were also able to partially restore the ability of EFR<sup>Y836F</sup> to support an elf18-induced oxidative burst (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>). This observation also extended to EFR<sup>SSAA</sup> (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), arguing that the F761[H/M] mutations support the ability of EFR to trans-activate BAK1.</p><p>EFR A-loop phosphorylation was reported previously to be indispensable for EFR function, and led to the hypothesis that it controls conformational switching, despite EFR being a non-RD kinase (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>). Our finding that the F761H mutation restores EFR<sup>SSAA</sup> function further supports this hypothesis. Nevertheless, how EFR A-loop phosphorylation facilitates conformational switching is unclear. In our AlphaFold2 models of the EFR kinase domain, we noted that two basic residues from the β3-αC loop and the αC-helix extend toward the A-loop and, similar to PKA H87 (<xref ref-type="bibr" rid="bib39">Meharena et al., 2016</xref>), may coordinate A-loop phosphorylation (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>).</p></sec><sec id="s2-4"><title>EFR F761H restores function of EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> in <italic>Arabidopsis</italic></title><p>We next generated stable <italic>Arabidopsis</italic> complementation lines expressing <italic>pEFR::EFR(variant)-GFP::HSP18t</italic> constructs in the null <italic>efr-1</italic> background. Because the F761H mutation showed greater ability than F761M to rescue function of both EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>), we chose this secondary mutation for the generation of complementation lines. Two independent homozygous complementation lines were isolated, with similar accumulation of EFR-GFP protein in the T3 generation. For EFR<sup>F761H/Y836F</sup>, only one homozygous T3 line could be isolated, so a heterozygous T2 line with two T-DNA insertion events was used for physiological experiments. Similar to experiments in <italic>N. benthamiana,</italic> the oxidative burst was partially restored in stable <italic>Arabidopsis</italic> complementation lines that express EFR<sup>F761H/Y836F</sup> or EFR<sup>F761H/SSAA</sup> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>).</p><p>The oxidative burst is only one of multiple cellular responses triggered by elf18. We therefore also tested whether other immune signaling responses are restored in the EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> complementation lines. Consistent with previous results, EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> lines were both less sensitive to treatment with 5 nM elf18 than those with wild-type EFR in seedling growth inhibition (SGI) assays (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Macho et al., 2014</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). As expected, both independent complementation lines of EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> exhibited enhanced SGI compared to EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup>, respectively (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). We also observed that MAPK activation was abolished or severely impaired in both EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> complementation lines (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>) and recovered in EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> complementation lines (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>).</p><p>The recovery of multiple immune responses in EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> complementation lines suggested that they retain fully functional elf18 signaling and that effective resistance against bacteria can be established. To confirm this, we tested the transgenic lines for resistance against <italic>Agrobacterium tumefaciens</italic>. Infection by this bacterium is restricted in <italic>Arabidopsis</italic> by EFR, so loss-of-function mutants like <italic>efr-1</italic> are more susceptible (<xref ref-type="bibr" rid="bib76">Zipfel et al., 2006</xref>). <italic>A. tumefaciens</italic> carrying a plasmid with an intronic version of the <italic>β-glucuronidase</italic> (<italic>GUS</italic>) gene was used to evaluate infection success. GUS activity in plant protein extracts following infection correlates with the ability of the bacteria to transiently transform plant cells. Significant GUS activity was detected in <italic>efr-1</italic> (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), consistent with successful <italic>A. tumefaciens</italic> infection, but only little was seen in wild-type EFR complementation lines, reflecting resistance to infection (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>; <xref ref-type="bibr" rid="bib76">Zipfel et al., 2006</xref>). The EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> complementation lines were both more susceptible to <italic>A. tumefaciens</italic> transformation than wild-type EFR complementation lines, as indicated by elevated GUS activity (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), but this was greatly diminished in the EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> complementation lines. Hence, these experiments show that the EFR F761H mutation restores full signaling function of EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> and thus resistance against <italic>A. tumefaciens<sc>.</sc></italic></p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> recover receptor complex activation.</title><p>(<bold>A</bold>) In infection assays, GUS activity was high in the positive control <italic>efr-1</italic> line. GUS activity level was reduced in the EFR<sup>WT</sup> and EFR<sup>F761H</sup> complementation lines, but much less so in the EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> complementation lines. By contrast, EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> complementation lines displayed substantially repressed GUS activity. Each experiment was repeated three times with similar results. Outliers are indicated by an additional asterisk and included in statistical analysis. Statistical test: Kruskal-Wallis test (<italic>P</italic>=5.704*10<sup>–7</sup>), Dunn’s post-hoc test with Benjamin-Hochberg correction (<italic>P</italic> ≤ 0.05) Groups with like lowercase letter designations are not statistically different. (<bold>B</bold>) In IP kinase assays, ligand-induced interaction of EFR<sup>WT</sup> and EFR<sup>F761H</sup> with BAK1 increased transphosphorylation of BIK1<sup>D202N</sup>, but this was abolished for EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup>. Both EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> showed partially restored BIK1<sup>D202N</sup> trans-phosphorylation as well as BAK1 S612 phosphorylation (across four replicates for EFR<sup>F761H/SSAA</sup> and in two out of four replicates for EFR<sup>F761H/Y836F</sup>). Samples were also probed for MAPK phosphorylation for effective ligand treatment. Treatment: 100 nM elf18 for 10 min. (<bold>C</bold>) Quantification of BIK1<sup>D202N</sup> band intensity observed in autoradiographs from the four independent replicates performed. Dotted red line indicates unchanged band intensity in mock vs. elf18 treatment.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw data for autoradiography and immunoblotting in <xref ref-type="fig" rid="fig3">Figure 3B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig3-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Multiple immune signaling branches are partially restored in EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup>.</title><p>Stable transgenic complementation lines in the <italic>Arabidopsis efr-1</italic> background were generated and physiological experiments conducted in the T3 generation (except for EFR<sup>F761H /Y836F</sup>#5, which is a double insertion line in T2 generation). (<bold>A</bold>) In the oxidative burst assay, EFR F761H restored oxidative burst in EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> complementation lines. Two independent experiments were merged into one graph as WT controls showed comparable total oxidative burst. A third independent experiment was performed with similar results. Outliers are indicated by an additional asterisk and included in statistical analysis. Statistical test: Kruskal-Wallis test (p&lt;2.2*10<sup>–16</sup>), Dunn’s post-hoc test with Benjamin-Hochberg correction (p ≤ 0.05) Groups with like letter designations are not statistically different. Like oxidative burst assays, EFR F761H restored SGI (<bold>B</bold>) and MAPK activation (<bold>C</bold>) in EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> complementation lines. For SGI assays, four independent experiments wtih 5 nM elf18 treatment are shown. Outliers are indicated by an additional asterisk and included in statistical analysis. Statistical test: Kruskal-Wallis test (p&lt;2.2 *10<sup>–16</sup>), Dunn’s post-hoc test with Benjamin-Hochberg correction (p ≤ 0.05) Groups with like letter designations are not statistically different. For MAPK activation assays, a representative experiment is shown. Similar results were obtained in three more experiments.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Raw data for immunoblots shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig3-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title><sc>EFR<sup>F761H/Y836F</sup></sc> and EFR<sup>F761H/SSAA</sup> restore BIK1 trans-phosphorylation</title><p>As shown <xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, EFR<sup>Y836F</sup> and EFR<sup>SSAA</sup> are impaired in elf18-triggered immune signaling at the level of receptor complex activation. In both cases BAK1 S612 phosphorylation is reduced, resulting in compromised ability to <italic>trans</italic>-phosphorylate BIK1. We therefore asked next whether EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> show restored ability to induce BAK1 autophosphorylation and resulting BIK1 trans-phosphorylation. We performed semi-in vivo IP-kinase assays in which EFR-GFP variants were immunoprecipitated from 2-week-old seedlings after 10 min mock or 100 nM elf18 treatment, and kinase activity of the complex was assessed by monitoring phosphorylation of recombinant His-BIK1<sup>D202N</sup> substrate. The EFR<sup>WT</sup>-GFP-BAK1 complex showed pronounced BIK1 phosphorylation compared with the unliganded control (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>). In contrast, although BAK1 co-precipitated with both EFR<sup>Y836F</sup>-GFP and EFR<sup>SSAA</sup>-GFP after elf18 treatment, these complexes failed to increase BIK1<sup>D202N</sup> trans-phosphorylation compared with the unliganded controls. They also showed reduced levels of BAK1 phosphorylation at S612 (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>). However, BAK1 S612 phosphorylation (for EFR<sup>F761H/Y836F</sup> in two out of four experiments) and BIK1<sup>D202N</sup> trans-phosphorylation were partially restored for EFR<sup>F761H/Y836F</sup> and EFR<sup>F761H/SSAA</sup> in this assay (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>), arguing that the functional rescue observed in vivo reflects BAK1 activation effects.</p></sec><sec id="s2-6"><title>Toward a mechanistic understanding of BAK1 allosteric activation by EFR</title><p>A phospho-ablative mutation of the BAK1 VIa-Tyr (Y403F) – analogous to Y836F in EFR – has also been reported to compromise elf18-induced signaling by interfering with receptor complex activation (<xref ref-type="bibr" rid="bib49">Perraki et al., 2018</xref>). We recapitulated this finding using only the intracellular domains of EFR and BAK1, fusing them to FKBP and FRB domains with myristoylation sequences and inducing dimerization with Rap in <italic>N. benthamiana</italic> (<xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). This approach allowed us to investigate BAK1 variants without interference of endogenous NbSERKs. We wondered whether BAK1<sup>Y403F</sup> could be rescued by a mutation analogous to EFR<sup>F761H/M</sup> to recover accessibility of the active conformation. Indeed, introducing the analogous mutation (I338H) into BAK1 partly restored the oxidative burst for BAK1<sup>I338H/Y403F</sup> when dimerized with EFR<sup>WT</sup> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), suggesting that BAK1<sup>Y403F</sup> is perturbed, like EFR<sup>Y836F</sup>, in accessing its active conformation. Analogies with allosteric regulation of other kinases and pseudokinases (<xref ref-type="bibr" rid="bib20">Hu et al., 2013</xref>; <xref ref-type="bibr" rid="bib35">Mace and Murphy, 2021</xref>; <xref ref-type="bibr" rid="bib60">Sheetz and Lemmon, 2022</xref>; <xref ref-type="bibr" rid="bib75">Zhang et al., 2006</xref>) led us hypothesize that EFR might stabilize the active-like conformation of BAK1 intermolecularly – helping to position the BAK1 αC-helix (in the EFR-BAK1 complex) to activate immune signaling. If this is correct, EFR that is partly ‘locked’ in its active-like conformation may be able to rescue (in trans) the function of a signaling-inactive BAK1 mutant with a destabilized αC-helix (as in BAK1<sup>Y403F</sup>). We therefore asked whether EFR<sup>F761H</sup> could achieve this, since it exhibited the tendency for increased BIK1<sup>D202N</sup> trans-phosphorylation in IP-kinase assays (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>) and for an accelerated oxidative burst in <italic>N. benthamiana</italic> (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and B</xref>). Intriguingly, when EFR<sup>F761H</sup> was paired with BAK1<sup>Y403F</sup>, the Rap-induced oxidative burst was partially restored (<xref ref-type="fig" rid="fig4">Figure 4</xref>), suggesting that EFR<sup>F761H</sup> can partially restore BAK1<sup>Y403F</sup> function. The fact that no oxidative burst was seen when EFR<sup>F761H</sup> was paired with catalytically inactive BAK1<sup>D416N</sup> suggests that this restoration does not occur through a direct catalytic mechanism mediated by EFR<sup>F761H</sup> (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>), supporting the hypothesis of allosteric regulation.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>EFR<sup>F761H</sup> recovers BAK1<sup>Y403F</sup> function.</title><p>The cytoplasmic domains of BAK1 and EFR variants with fused RiD-tags were transiently expressed in <italic>N. benthamiana</italic> and leaf discs were treated with Rap to induce dimerization. EFR and EFR<sup>F761H</sup> induced a similar total oxidative burst when BAK1 was co-expressed. The co-expression of BAK1<sup>Y403F</sup> and EFR diminished the oxidative burst, which was restored partially when EFR<sup>F761H</sup> was co-expressed. Outliers are indicated by an additional asterisk and included in statistical analysis. Statistical test: Kruskal-Wallis test (p&lt;8.516 *10<sup>–7</sup>), Dunn’s post-hoc test with Benjamin-Hochberg correction (p ≤ 0.05) Groups with like letter designations are not statistically different.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Function of BAK1 Y403F is partially recovered by the secondary mutation I338H.</title><p>(<bold>A</bold>) The RiD system was utilized to test the recovery of BAK1 Y403F by transient expression in <italic>N. benthamiana</italic>. The Y403F mutation in BAK1 diminished the oxidative burst, whereas BAK1 I338H displayed near WT-like responses. Combining the I338H and Y403F mutations, however, led to a partial recovery of oxidative burst. Outliers are indicated by an additional asterisk and included in statistical analysis. Statistical test: Kruskal-Wallis test (p&lt;2.247 *10<sup>–11</sup>), Dunn’s post-hoc test with Benjamin-Hochberg correction (p ≤ 0.05) Groups with like letter designations are not statistically different. (<bold>B</bold>) SDS-PAGE analysis of protein levels in experiments 2 and 3 of A is shown. Protein accumulation data for experiment 1 was not collected.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Raw data for immunoblots shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig4-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>EFR F761H accelerates the onset of the oxidative burst but requires the catalytic activity of BAK1.</title><p>(<bold>A</bold>) Quantification of the time until the oxidative burst reaches its half maximum from experiments presented in <xref ref-type="fig" rid="fig2">Figure 2B</xref>. Both putative activating mutations, F761H and F761M accelerate the onset of the oxidative burst. (<bold>B</bold>) Time resolved oxidative burst assay. Presented curves are from replicate number three as a representative example. Graphs in A and B are based on data presented in <xref ref-type="fig" rid="fig2">Figure 2B</xref>. Error bars represent standard error of the mean (n=4). (<bold>C</bold>) EFR F761H requires the catalytic activity of BAK1 to induce the oxidative burst. Data from three independent experiments is merged in one graph. (<bold>D</bold>) Protein accumulation of the RiD-tagged protein related to panel C. Statistical analysis in A and C: Outliers are indicated by an additional asterisk and included in statistical analysis. Statistical test: Kruskal-Wallis test (p=1.686*10<sup>–8</sup> in A, p=5.89910<sup>–8</sup> in C), Dunn’s post-hoc test with Benjamin-Hochberg correction (p ≤ 0.05) Groups with like letter designations are not statistically different.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Raw data for immunoblots shown in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig4-figsupp2-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Protein accumulation for the oxidative burst assay in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title><p>Leaf discs were collected after the oxidative burst assay and protein was extracted by boiling in SDS-loading buffer followed by immunoblotting. Non-infiltrated leaf discs served as negative control.</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Raw data for immunoblots shown in <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig4-figsupp3-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig4-figsupp3-v1.tif"/></fig></fig-group></sec><sec id="s2-7"><title>Catalytic independence is only observed for <italic>Arabidopsis</italic> sp. LRR-RK XIIa kinase domains</title><p>EFR belongs to LRR-RK subfamily XIIa (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), of which two other RKs are functionally described immune RKs in <italic>Arabidopsis</italic>: FLS2 and XPS1 (XANTHINE/URACIL PERMEASE SENSING 1) (<xref ref-type="bibr" rid="bib15">Gómez-Gómez and Boller, 2000</xref>; <xref ref-type="bibr" rid="bib44">Mott et al., 2016</xref>). This subfamily has been implicated more generally in immune signaling, which is supported by induction of immune signaling of in vivo dimerized FLS2, EFR, or XPS1-LIKE 1 (FEXL1) intracellular domains with BAK1 (<xref ref-type="bibr" rid="bib24">Kim et al., 2021</xref>). However, the ligands are not known for most subfamily-XIIa RKs (<xref ref-type="bibr" rid="bib11">Dufayard et al., 2017</xref>; <xref ref-type="bibr" rid="bib24">Kim et al., 2021</xref>). Because EFR does not require its catalytic activity, we wondered whether other LRR-RK XIIa kinase domains similarly function non-catalytically, in a manner similar to pseudokinases. To test this hypothesis, we fused the EFR ectodomain to the transmembrane helix and intracellular domain of different LRR-RK XIIa members to generate elf18 responsive RKs that can dimerize with BAK1/SERKs (<xref ref-type="bibr" rid="bib52">Rhodes et al., 2021</xref>). These chimeric proteins were expressed transiently in <italic>N. benthamiana</italic> leaves, and their immune signaling function was tested by elf18 treatment in oxidative burst assays. All chimeras induced an oxidative burst (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), except XIIa2 (the closest FLS2-related kinase), which exhibited only a very minor response. To determine whether their signaling function required kinase activity, we next tested variants with mutations in the catalytic site (replacing the putative catalytic base HRD-aspartate with asparagine). EFR<sup>D849N</sup> induced a robust oxidative burst as expected as well as FEXL1<sup>D838N</sup> and the closely related XIIa5<sup>D839N</sup> (AT3G47570). Similarly, XPS1<sup>D856N</sup> and XIIa6<sup>D840N</sup> (AT3G47090) induced an oxidative burst independently of their catalytic activity, but the total oxidative burst was reduced compared to the catalytically active variants. Protein levels of catalytic site mutants accumulated comparably to their corresponding wild-type versions (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). In contrast, the catalytically inactive FLS2<sup>D997N</sup> showed a diminished oxidative burst (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), suggesting that it may be mechanistically distinct. Furthermore, kinetic differences for the oxidative burst of <italic>Arabidopsis</italic> XIIa kinase domains were observed. XPS1<sup>D856N</sup> and XIIa6<sup>D840N</sup> showed a delayed oxidative burst (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>). Also, EFR<sup>D849N</sup> exhibited a delay of approximately 5–7 min compared to wild-type EFR. In contrast, oxidative bursts induced by FEXL1<sup>D838N</sup> and XIIa5<sup>D839N</sup> were only slightly delayed compared to their corresponding catalytically active kinase domains. We corroborated these findings for XIIa5 by performing in vitro kinase assays, observing that BIK1<sup>D202N</sup> and BAK1 phosphorylation increased after Rap application as effectively for XIIa5<sup>D839N</sup> as for wild-type XIIa5 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C and D</xref>). Taken together, our results imply that catalytic activity for XIIa5 is almost fully dispensable.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Related EFR kinases from LRR-RK XIIa in the <italic>Arabidopsis</italic> genus can function independent of their calatytic activity.</title><p>(<bold>A</bold>) Phylogenetic analysis of LRR-RK subfamily XIIa. Selected LRR-RK XIIa kinase domains are labeled and highlighted with purple points. The EFR-like clade contains all <italic>Arabidopsis</italic> XIIa kinases except FLS2 and XIIa2 and also selected XIIa kinases from <italic>Arabidopsis lyrata</italic> and <italic>Brassica rapa</italic>. (<bold>B, C</bold>) The ectodomain of EFR was fused to the transmembrane and intracellular domain of selected LRR-RK XIIa members to create elf18-responsive chimeras for testing the immune signaling function and catalytic dependency of the related kinase domains. The chimeras were transiently expressed in <italic>N. benthamiana</italic> and tested in oxidative burst assays. All <italic>Arabidopsis</italic> LRR-RK XIIa members induced an oxidative burst except XIIa2, the closest FLS2 related kinase in the subfamily. Catalytic dependency of the kinase domains appears to vary from kinase to kinase, with catalytically dead versions of EFR, FEXL1 and XIIa5 inducing a WT-like oxidative burst and XPS1 and XIIa6 displaying a reduced oxidative burst. FLS2 kinase dead exhibited a diminished oxidative burst. Experiments were repeated three times with similar results.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>XIIa5<sup>D839N</sup> exhibits largely XIIa5WT-like characteristics.</title><p>(<bold>A, B</bold>) Catalytic site mutation of XIIa5 exhibited the least delayed onset of oxidative burst. In A, quantification of the time to reach the half maximum of the oxidative burst is shown. The underlying data are the same as used for total oxidative burst in the main figure. In B, the actual oxidative burst curves are presented as average of six individual plants transiently expressing the indicated chimeric protein. Error bars represent standard error of the mean (n=6). (<bold>C</bold>) A catalytic site mutation of XIIa5 did not negatively affect BIK1 trans-phosphorylation or BAK1 autophosphorylation. Experiments were performed as described in <xref ref-type="fig" rid="fig1">Figure 1</xref>. (<bold>D</bold>) Quantification of band intensities on autoradiographs from three independent experiments are shown. BRI1<sup>D1009N</sup> and EFR<sup>D849N</sup> displayed results similar to <xref ref-type="fig" rid="fig1">Figure 1B and C</xref>. In contrast to EFR<sup>D849N</sup>, for which BIK1 and BAK1 relative band intensities slightly decreased compared to wild type EFR, BIK1<sup>D202N</sup> and BAK1 relative band intensities were wild-type-like for XIIa5<sup>D839N</sup>.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Raw data for autoradiography shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig5-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Protein accumulation of EFR-XIIa chimeras in <italic>N</italic>. <italic>benthamiana</italic>.</title><p>All constructs exhibited detectable protein accumulation in transiently transformed <italic>N. benthamiana</italic> leaves. Similar protein accumulation was observed in 3 replicates for (<bold>A</bold>). Protein accumulation for constructs in (<bold>B</bold>) was tested once.</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Raw data for autoradiography shown in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92110-fig5-figsupp2-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92110-fig5-figsupp2-v1.tif"/></fig></fig-group><p>Because most <italic>Arabidopsis</italic> LRR-RK XIIa kinase domains execute their signaling function at least to some extent independently of their catalytic activity, we went on to test XIIa kinase domains from other species, that we selected from a phylogenetic tree of LRR-RK XIIa kinases built from previous phylogenetic analysis (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="bibr" rid="bib11">Dufayard et al., 2017</xref>). The selected catalytically active XIIa kinase domains from <italic>Oryza sativa</italic> (XA21)<italic>, Populus trichocarpa</italic> (PtXIIa), <italic>Solanum lycopersicum</italic> (SlXIIa), <italic>Glycine max</italic> (GmXIIa), <italic>Brassica rapa</italic> (BrEFR), and <italic>Arabidopsis lyrata</italic> (AlEFR), induced an oxidative burst (<xref ref-type="fig" rid="fig5">Figure 5C</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>). However, catalytic site mutants of all non-<italic>Arabidopsis</italic> XIIa RKs accumulated similar to their wild-type counterparts and abolished their function in oxidative burst assays (<xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our study provides insights into the non-catalytic activation mechanisms of the EFR-BAK1 complex. Rather than requiring its kinase activity to transactivate BAK1, our results suggest that the EFR kinase domain undergoes a ‘conformational toggle’ to an active-like state that permits allosteric <italic>trans</italic>-activation of BAK1. EFR function is impaired by perturbation of structural elements that are important for conformational switching – specifically, mutation of the subdomain VIa Y836 or ablation of A-loop phosphorylation sites – but these effects can be reversed by intragenic suppressor mutations that stabilize the active-like conformation, notably the F761H mutation.</p><p>Non-catalytic functions of kinases and pseudokinases are human disease-relevant and have emerged as important signaling regulators in metazoans (<xref ref-type="bibr" rid="bib12">Eyers and Murphy, 2013</xref>; <xref ref-type="bibr" rid="bib35">Mace and Murphy, 2021</xref>; <xref ref-type="bibr" rid="bib55">Schmidt et al., 2021</xref>; <xref ref-type="bibr" rid="bib60">Sheetz and Lemmon, 2022</xref>). By comparison, very little is known about pseudokinases or non-catalytic kinase functions in plants, although pseudokinases are as prevalent in plant as in metazoan kinomes (<xref ref-type="bibr" rid="bib26">Kwon et al., 2019</xref>). Our data demonstrate that EFR and potentially other <italic>Arabidopsis</italic> XIIa kinases function as allosteric regulators of BAK1 kinase activity, implying pseudokinase-like functions. Thus, our findings establish precedence for non-catalytic mechanisms, specifically allosteric regulation, in plant RK signaling.</p><p>Phosphorylation of EFR is crucial for signaling function and potentially supports the conformational toggle. Nevertheless, our results do not resolve how phosphorylation of the A-loop or VIa-Tyr facilitate conformational toggling for EFR, and structural studies will be required to address this question. However, our HDX-MS analysis of unphosphorylated protein suggests that EFR<sup>Y836F</sup> causes the active-like conformation to become inaccessible, potentially due to a lack of an inter-lobe H-bond – consistent with earlier studies describing the corresponding VIa-Tyr as a pivot for αC-helix movements in PKA (<xref ref-type="bibr" rid="bib63">Taylor and Kornev, 2011</xref>; <xref ref-type="bibr" rid="bib67">Tsigelny et al., 1999</xref>). Recent analysis of the PKA hinge region demonstrates the importance of its integrity for coordinated conformational changes in the N- and C-lobe (<xref ref-type="bibr" rid="bib47">Olivieri et al., 2023</xref>; <xref ref-type="bibr" rid="bib73">Wu et al., 2023</xref>). Whether EFR VIa-Tyr phosphorylation contributes to these coordinated conformational changes is unclear. We attempted to directly address the role of pY836 in EFR conformational dynamics using HDX-MS but were unable to produce sufficient recombinant protein with a pTyr-analog incorporated at the Y836 site. However, phosphorylation of the VIa-Tyr presumably distorts the hinge region due to its proximity to the αC-β4-loop. Alternatively, the VIa-pTyr and C-terminal end of the αE-helix must rotate outwards (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Rotation of the αE-helix, however, would have direct impact on the positioning of the catalytic loop and RS1. Of note, functional importance of VIa-Tyr phosphorylation was assigned based on correlation between its phosphorylation and functional impairment by phenylalanine substitution in multiple plant RKs (<xref ref-type="bibr" rid="bib32">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Luo et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Macho et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Perraki et al., 2018</xref>), making it possible that functional importance of its phosphorylation confounded a structural role. Future computational protein-structure prediction techniques that consider post-translational modifications will aid in elucidating the effect of EFR VIa-Tyr phosphorylation on EFR’s conformation. Nevertheless, mutation of VIa-Tyr may be a useful tool to break pseudokinase/non-catalytic functions by impeding conformational toggling in a way that is more effective than using conventional kinase-dead mutations.</p><p>Basal BAK1 activity in vitro is low compared to its robustly enhanced activity after Rap-induced dimerization (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C and D</xref>), which might be further reduced in planta by negative regulators (e.g. protein phosphatases; <xref ref-type="bibr" rid="bib58">Segonzac et al., 2014</xref>). We propose that, by increasing the local concentration, ligand-induced association of EFR and BAK1 allows partially active BAK1 to phosphorylate the adjacent EFR A-loop. This in turn allows wild-type EFR to adopt the active-like conformation that can allosterically fully activate BAK1 to promote substrate phosphorylation. The activating mutation EFR F761H potentially circumvents the requirement of A-loop phosphorylation since it partially restored EFR<sup>SSAA</sup> function. Consistently, EFR<sup>F761H</sup> showed elevated BIK1 trans-phosphorylation in IP-kinase assays and an accelerated oxidative burst (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A, B</xref>), suggesting constitutive assembly of the active-like conformation. However, EFR<sup>F761H</sup> still requires catalytic activity of complexed BAK1 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).</p><p>Our data demonstrate that allosteric BAK1 kinase activation plays a key role in EFR-BAK1-mediated immune signaling. The partial recovery of BAK1<sup>Y403F</sup>, which we hypothesize is impaired in αC-helix positioning, by EFR<sup>F761H</sup> suggests a mechanism for allosteric regulation involving BAK1 αC-helix positioning. Indeed, multiple metazoan kinases are allosterically regulated by αC-helix positioning (<xref ref-type="bibr" rid="bib60">Sheetz and Lemmon, 2022</xref>). Moreover, BAK1 has a high propensity for a disordered αC-helix (<xref ref-type="bibr" rid="bib43">Moffett et al., 2017</xref>), suggesting its correct positioning requires additional support. Different orientations of kinase-kinase dimers, in which allosteric regulation occurs at the αC-helix, were previously described (<xref ref-type="bibr" rid="bib35">Mace and Murphy, 2021</xref>; <xref ref-type="bibr" rid="bib60">Sheetz and Lemmon, 2022</xref>). Structural analysis will be required to resolve the exact interaction interface for allosteric activation in the EFR-BAK1 kinase dimer and to design interface-disrupting mutations for structure-function analysis but is beyond the scope of the present work.</p><p>Allosteric activation of BAK1/SERKs is partially preserved in <italic>Arabidopsis</italic> LRR-RK XIIa kinases (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Whether these kinases function solely non-catalytically, as suggested by XIIa5<sup>D839N</sup> (<xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), or contribute also catalytically to signaling activation is unclear since oxidative bursts induced by all functional catalytic base mutants of XIIa kinases were delayed (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>). Catalytic base mutation may affect conformational dynamics, which we show are important for EFR function (<xref ref-type="fig" rid="fig2">Figure 2</xref>), confounding our interpretation. Inactive XIIa kinases with intact conformational dynamics may clarify the extent of catalytic contribution and could be obtained by development of selective inhibitors or engineering analog sensitive kinases. Alternatively, catalytic independency could be a recent innovation in <italic>Arabidopsis</italic> sp. XIIa kinases, that is taxonomically restricted due to a strong negative selection on the kinase domain (<xref ref-type="bibr" rid="bib37">Man et al., 2023</xref>) but further study is required to test this hypothesis.</p><p>Taken together, our results add to growing evidence that non-catalytic functions of kinases are similar to <italic>bona fide</italic> kinases controlled by conformational switching (<xref ref-type="bibr" rid="bib59">Sheetz et al., 2020</xref>; <xref ref-type="bibr" rid="bib60">Sheetz and Lemmon, 2022</xref>) and further set precedence for discovering more non-catalytic mechanisms in plant RK signaling where pseudokinases are particularly prevalent (<xref ref-type="bibr" rid="bib26">Kwon et al., 2019</xref>).</p><sec id="s3-1"><title>Limitations of the study</title><p>In our in vitro kinase assays using the RiD system, the proteins were freely diffusing as they were produced as soluble entities. Freely diffusing components, however, do not fully resemble the in planta mode of activation where the plasma membrane restricts the free movement. The colocalization of RK/coRK complexes with their substrates may be a supporting component of signaling activation, which we did not capture in our in vitro assays.</p><p>It is yet unclear whether EFR phosphorylates BAK1 efficiently on activation-relevant residues in the context of stabilized proximity. This information will ultimately help to deduce whether the catalytic activity of EFR contributes to signaling activation and whether even marginal catalytic activity of EFR<sup>D849N</sup> may be sufficient to support signaling activation.</p><p>Further, our study relies heavily on mutations. Mutations can have pleiotropic effects as they impact conformational plasticity which supports catalytic activity and non-catalytic functions. Thus, it is difficult to untangle catalytic from non-catalytic functions using solely mutations. Eventually, it would be beneficial to obtain structural information of native proteins in a complex and monitor site-specific and time-resolved phosphorylation on complex components.</p><p>We do not have experimental support for EFR<sup>F761H</sup> stabilizing or facilitating the transition into an active-like conformation and relieving the negative effect of the Y836F mutation in EFR<sup>F761H/Y836F</sup>. It would have been beneficial to obtain HDX-MS data for these mutants as well, but we could not produce sufficient protein to do so. Thus, we rather derived the biochemical and structural effects of the EFR<sup>F761H</sup> mutant by homology to mammalian kinases, for example BRAF.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Plant material and growth conditions</title><p>For complementation experiments, the <italic>efr-1</italic> T-DNA insertional mutant was used (<xref ref-type="bibr" rid="bib76">Zipfel et al., 2006</xref>). A comprehensive list of transgenic line used in this study can be found in the Key Resources Table.</p><p>For sterile plant culture, the growth conditions were 120 μmol s<sup>–1</sup> m<sup>–2</sup> illumination during 16 hr light/8 hr dark cycles at a constant temperature of 22 °C. Sterilization of seeds was performed by chlorine gas surface sterilization for 6 hr. Sterile seeds were germinated on 0.8% (w/v) phyto agar plates containing 0.5 x Murashige and Skoog (MS, Duchefa) basal salt mixture and 1% (w/v) sucrose. After 5 days of growth on agar plates, seedlings were transferred to liquid 0.5 x MS medium containing 1% (w/v) sucrose in either sterile 6- (IP-kinase), 24- (MAPK activation), or 48-well (seedling growth inhibition) plates.</p><p>For plant growth on soil, seeds were resuspended in 0.05% (w/v) agarose solution and stratified for at least 16 hr in the dark at 4 °C. Seeds were then directly sown on soil using a Pasteur pipette.</p></sec><sec id="s4-2"><title>Physiological assays</title><sec id="s4-2-1"><title>Seedling growth inhibition assay</title><p>Upon transfer to liquid culture, seedlings were exposed to either mock (no PAMP supplementation) or PAMP (5 nM elf18) treatment. After 10 days of seedling growth in liquid culture, seedlings were dry blotted on a paper towel to remove excess liquid media before measuring their fresh weight using a fine balance (Sartorius X64-S1). The relative seedling weight was calculated by dividing the seedling weight of each PAMP treated seedling by the average seedling weight of all mock-treated seedlings of the respective genotype.</p></sec><sec id="s4-2-2"><title>MAPK activation assay</title><p>After transfer to liquid media, seedling growth continued for 10 days. The liquid medium was then decanted from the 24-well plate, and 1 ml of liquid 0.5 x MS-medium containing either no elf18 supplementation (mock) or 100 nM elf18 supplementation was added to each well and seedlings incubated for 10 min. Thirty seconds prior to the end of this incubation, seedlings were dry blotted on a paper towel, transferred to a 1.5 ml reaction tube, and flash frozen in liquid nitrogen. Frozen tissue was then stored at –80 °C.</p><p>For protein extraction, the frozen tissue was ground using a plastic pestle in the 1.5 ml microcentrifuge tube and analyzed as described.</p></sec><sec id="s4-2-3"><title>Measurement of apoplastic oxidative burst</title><p>Four- to 5-week-old under a short day regime (130 μmol s<sup>–1</sup> m<sup>–2</sup>, 65% humidity, 10 hr/14 hr light/dark-cycle) soil-grown plants were used for punching out at least two leaf discs (4 mm in diameter) per plant. Leaf discs were floated on ultrapure water in a white chimney 96-well plate. The next day, the water solution was replaced with assay solution containing 100 nM elf18, 100 μM luminol and 10 μg/ml horseradish peroxidase, immediately before recording luminescence in 1 min intervals with 250 ms integration time per well in a Tecan Spark plate reader. The luminescence recorded of all leaf discs coming from the same plant were averaged for each time point. For plotting the time course of recorded luminescence emission, the means of all plants belonging to the same genotype were averaged and the standard error of the mean was calculated, which is represented by the error bar. For calculating the time to half maximum, the timepoint of maximum oxidative burst was determined and the next five values included for fitting a sigmoidal curve to the oxidative burst of each leaf disc. From the fitted function, the half maximum was derived and all half maxima from leaf discs belonging to one plant were averaged.</p></sec><sec id="s4-2-4"><title>Infection assay with GUS activity monitoring</title><p>Three to four-week-old plants were infiltrated with <italic>A. tumefaciens</italic> carrying pBIN19-GUS(intronic) at OD<sub>600</sub>=0.5. <italic>A. tumefaciens</italic> was inoculated the day before and grown overnight. Five days after infiltration, infiltrated leaves were harvested into a 2 ml microcentrifuge tube with two ø4 mm glass beads and flash frozen in liquid nitrogen. Plant tissue was ground in a GenoGrinder (90 s, 1500 rpm). A total of 600 μl of extraction buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>-NaOH, pH 7.0, 10 mM EDTA, 0.1% (v/v) Triton X-100, 0.1% (v/v) sodium lauroyl sarcosinate, 10 mM β-mercaptoethanol) was added to tissue powder and incubated for 30 min on a rotator at 4 °C. Protein extracts were centrifuged (10 min, 13,000 rpm, 4 °C) in a table top centrifuge, and 200 µl supernatant was collected. 100 μl of the supernatant was mixed with 100 μl extraction buffer containing 2 mM 4-methylumbelliferyl-β-D-glucopyranoside and incubated for 30 min at 37 °C. 40 μl of the reaction was collected and mixed with 160 µl Na<sub>2</sub>CO<sub>3</sub> to stop the reaction and enhance the fluorescence of 4-methylumbelliferone. A standard curve of 4-methylumbelliferone in extraction buffer was prepared, starting with 10 μM and using twofold dilution steps. Finally, fluorescence was measured in a plate reader. Protein concentration was determined using Bradford reagent with 1:20 dilution of protein extract. Fluorescence was converted into 4-MU concentration using the standard curve and 4-MU concentration was normalized to the amount of protein in the 40 μl sample divided by the incubation time.</p></sec></sec><sec id="s4-3"><title>Molecular cloning</title><p>All primers and plasmids used and generated in this study are listed in the Key Resources Table.</p><p>For recombinant expression and in planta complementation, the gene’s cDNA sequences were subcloned from previously published cDNA clones (<xref ref-type="bibr" rid="bib3">Bender et al., 2021</xref>; <xref ref-type="bibr" rid="bib49">Perraki et al., 2018</xref>) or synthesized with domesticated BsaI, BpiI and Esp3I sites. PCR products were inserted into level 0 Golden-Gate plasmids pICSL01005, pICH41308 (<xref ref-type="bibr" rid="bib71">Weber et al., 2011</xref>), or the universal acceptor p641 (<xref ref-type="bibr" rid="bib6">Chiasson et al., 2019</xref>) respectively. GoldenGate reactions were performed with 5 U of restriction enzyme and 200 U of T4 ligase in T4 ligase buffer (NEB) also containing 0.1 mg/ml BSA (NEB; <xref ref-type="bibr" rid="bib71">Weber et al., 2011</xref>). GoldenGate digestion ligation cycles varied between 10 and 20.</p><p>Site directed mutagenesis (SDM) was conducted as described (<xref ref-type="bibr" rid="bib31">Liu and Naismith, 2008</xref>) or during GoldenGate cloning by amplifying the target in two pieces that were ligated in the restriction-ligation reaction with the intended nucleotide changes in the restriction overhangs. Where SDM was performed according to <xref ref-type="bibr" rid="bib31">Liu and Naismith, 2008</xref>, the PCR reaction was DpnI (New England Biolabs) digested (37 °C, 1–2 hr) without prior clean-ups, and then transformed into <italic>E. coli</italic> DH10b.</p><sec id="s4-3-1"><title>Construction of pICSL86955-35S::EFRecto-ccdB-mEGFP::HSP18t</title><p>The ccdB counter selection cassette was amplified from p641-Esp3I, and the EFR ectodomain sequence was amplified from pICSL01005-EFR using primers listed in the Key Resources Table. The PCR products were purified and used together with level 0 GoldenGate plasmids for 35 S promoter +TMVOmega 5’UTR, C-terminal mEGFP-tag and HSP18 terminator for assembly into pICSL86955 using BsaI (ThermoScientific) restriction enzyme and T4 DNA ligase (New England Biolabs). The GoldenGate restriction-ligation-reaction was transformed into <italic>E. coli</italic> One Shot ccdB Survival 2 T1R Competent Cells (Thermo Fisher). Single colonies were cultured for plasmid isolation and the cloned sequence was confirmed by DNA sequencing.</p></sec><sec id="s4-3-2"><title>Construction of p641-BsaI</title><p>Site-directed mutagenesis was performed according to <xref ref-type="bibr" rid="bib31">Liu and Naismith, 2008</xref>, using primers listed in the Key Resources Table using p641-EspI as template.</p></sec><sec id="s4-3-3"><title>Construction of pETGG</title><p>The plasmid pET28a(+)–6xHis-TEV-GB1 was linearized by PCR excluding 6xHis-TEV-GB1 sequences and the C-terminal 6xHis-tag that were replaced by the GoldenGate cloning cassette containing AATG and GCTT BsaI restriction sites, the ccdB counter selection marker, and the chloramphenicol resistance gene. The GoldenGate cloning cassette was amplified using primers listed in the Key Resources Table using p641-BsaI as template and the PCR product was ligated with the linearized pET28a(+) backbone using InFusion (Takara) cloning.</p></sec></sec><sec id="s4-4"><title>Plant transformation</title><sec id="s4-4-1"><title>Stable transformation of <italic>Arabidopsis thaliana</italic></title><p>For complementation of <italic>efr-1</italic> T-DNA knock-out lines, the coding sequence of EFR and the mutants were cloned in the GoldenGate system as described in the section <italic>Molecular cloning</italic>. Sequences of final binary plasmids were confirmed by sequencing prior to transformation into <italic>Agrobacterium tumefaciens</italic> GV3101 by electroporation (25 μF, 200 Ω, 1.8 kV). Plants were grown to the early flowering stage and then transformed using the floral dip method with bacteria grown in YEBS medium (<xref ref-type="bibr" rid="bib7">Clough and Bent, 1998</xref>; <xref ref-type="bibr" rid="bib9">Davis et al., 2009</xref>). Seeds after dip transformation were selected on 0.5 x MS-agar plates containing 10 μg/ml phosphinothricin until homozygous seed batches were identified in T3 generation. These seed batches were then used for physiological assays.</p></sec><sec id="s4-4-2"><title>Transient transformation of <italic>Nicotiana benthamiana</italic></title><p><italic>Agrobacterium tumefaciens</italic> was grown over night in liquid LB medium supplemented with kanamycin (50 µg/ml), gentamycin (25 µg/ml) and rifampicin (40 µg/ml). Cultures were diluted the next morning 1:10 in fresh LB medium (without antibiotics) and grown to an optical density OD<sub>600</sub> 0.8–1.2. Cultures were spun down (2000 rcf, 10 min) and LB medium was decanted. Pellet was resuspended in infiltration medium (10 mM MES-KOH, pH 5.8, 10 mM MgCl<sub>2</sub>), the optical density (OD<sub>600</sub>) was determined in a spectrophotometer. For infiltration, <italic>A. tumefaciens</italic> carrying the construct with the gene of interest and a second strain carrying the RNA silencing suppressor p19 were mixed at a 2:1 ratio (final OD<sub>600</sub>=0.5 + 0.25=0.75). The mixture was infiltrated into 4- to 5-week-old <italic>N. benthamiana</italic> plants from the abaxial site of the leaf with a needle-less 1 ml syringe. Constructs within one experiment were infiltrated side-by-side into the same leaf on multiple plants. Only for testing the catalytic requirement of multiple LRR-RK XIIa kinase domains, not all constructs could be infiltrated side-by-side on one leaf.</p></sec></sec><sec id="s4-5"><title>Protein extraction from plant samples</title><p>Flash frozen tissue was ground using plastic pestles in 1.5 ml microcentrifuge tubes or, in case of coIP and IP-kinase samples, using stainless steel grinding jars and a Retsch mill (90 s, 30 Hz). Ground tissue was mixed with extraction buffer 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10% glycerol, 2 mM EDTA, 1% IGEPAL detergent, 1 mM DTT, 4 mM sodium tartrate (Na<sub>2</sub>C<sub>4</sub>H<sub>4</sub>O<sub>6</sub>), 1% (v/v) protease inhibitor cocktail (P9599, Sigma), 1 mM PMSF, 2 mM sodium molybdate (Na<sub>2</sub>MoO<sub>4</sub>), 1 mM sodium fluoride (NaF), and 1 mM activated sodium orthovanadate (Na<sub>3</sub>VO<sub>4</sub>) at an 1:1 – 1:2 ratio (tissue powder:extraction buffer) and incubated for 30–45 min on a rotator at 4 °C. For, coIP or IP-kinase assays, the samples were filtered through two layers of Miracloth into conical centrifugation tubes, which were spun at 20,000 rcf for 20 min, and supernatant was collected. Protein concentrations in the supernatants were determined using Bradford reagent. Subsequently, protein concentration was adjusted to normalize samples.</p></sec><sec id="s4-6"><title>Recombinant protein expression and purification</title><p>For HDX-MS pET28a(+)–6xHis-EFR and pET28a(+)–6xHis-EFR Y836F were transformed by heat shock into BL21(DE3) pLPP (Amid Biosciences). Protein expression and purification was performed as described for proteins produced for the in vitro kinase assay. Conditions for growth and extraction are detailed in <xref ref-type="table" rid="table2">Table 2</xref>, except, that protein was eluted from the gel filtration column in 20 mM HEPES, pH 7.2 (NaOH), 150 mM NaCl.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Protein expression conditions.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Protein</th><th align="left" valign="bottom">T after induction [°C]</th><th align="left" valign="bottom">t of expression [h]</th><th align="left" valign="bottom">pH of extraction buffer</th></tr></thead><tbody><tr><td align="left" valign="bottom" colspan="4">For in vitro kinase assay</td></tr><tr><td align="left" valign="bottom">EFR/EFR D849N</td><td align="char" char="." valign="bottom">30</td><td align="char" char="." valign="bottom">4</td><td align="char" char="." valign="bottom">8.0</td></tr><tr><td align="left" valign="bottom">BAK1</td><td align="char" char="." valign="bottom">30</td><td align="char" char="." valign="bottom">4</td><td align="char" char="." valign="bottom">8.0</td></tr><tr><td align="left" valign="bottom">BRI1/BRI1 D1009N</td><td align="char" char="." valign="bottom">18</td><td align="left" valign="bottom">Over night</td><td align="char" char="." valign="bottom">8.0</td></tr><tr><td align="left" valign="bottom">FLS2/FLS2 D997N</td><td align="char" char="." valign="bottom">18</td><td align="left" valign="bottom">Over night</td><td align="char" char="." valign="bottom">8.0</td></tr><tr><td align="left" valign="bottom">BIK1 D202N</td><td align="char" char="." valign="bottom">18</td><td align="left" valign="bottom">Over night</td><td align="char" char="." valign="bottom">7.5</td></tr><tr><td align="left" valign="bottom" colspan="4">For HDX-MS</td></tr><tr><td align="left" valign="bottom">EFR/EFR Y836F</td><td align="char" char="." valign="bottom">30</td><td align="char" char="." valign="bottom">3</td><td align="char" char="." valign="bottom">8.0</td></tr></tbody></table></table-wrap><p>Unphosphorylated protein for in vitro RiD kinase assays were recombinantly produced in <italic>E. coli</italic> BL21(DE3)-V2R-pACYC LamP (<xref ref-type="bibr" rid="bib72">Wernimont et al., 2010</xref>). From a single colony, a 10 ml lysogeny broth (LB) starter culture supplemented with 50 μg/ml kanamycin and 15 μg/ml chloramphenicol was inoculated and incubated overnight at 37 °C, shaking at 220 rpm. On the next day, the starter culture was completely transferred to 1 l of LB medium containing 50 μg/ml kanamycin at 37 °C with shaking to an OD<sub>600</sub> of 0.6–0.8. With the addition of 300 μM isopropyl β-D-1-thiogalactopyranoside (IPTG), expression of recombinant protein was induced, and growth continued with conditions indicated in <xref ref-type="table" rid="table2">Table 2</xref>. Cells were then pelleted by centrifugation at 4000 rcf for 10 min, and pellets resuspended in protein extraction buffer (20 mM HEPES-NaOH at varying pH (see <xref ref-type="table" rid="table2">Table 2</xref>), 500 mM NaCl, 10 mM imidazole, 5% glycerol). Resuspended bacterial pellets were stored at –80 °C before protein purification.</p><p>Frozen pellet suspensions were thawed in a water bath at room temperature and then transferred to ice. Cells were lysed using ultrasonication (Branson Sonifier 250) with a ø6 mm sonicator probe at 60% amplitude, with 20 s ON/40 s OFF intervals for a total of 4 cycles. Cell debris was pelleted by centrifugation at 47,850 rcf for 30 min at 4 °C. The supernatant was collected and equilibrated PureCube 100 Co-NTA agarose beads (Cube Biotech) were added for batch-binding of protein. Binding continued for 45 min while rotating at 14 rpm on a tabletop rotator at 4 °C. Beads were collected by centrifugation at 500 rcf for 1 min at 4 °C, and supernatant was removed using a vacuum pump. Beads were then washed twice with 10 ml ice-cold protein extraction buffer, and protein eluted in elution buffer (20 mM HEPES-NaOH, pH 8.0, 300 mM NaCl, 300 mM imidazole, 5% glycerol) by incubation for 10 min, followed by spinning down beads and collecting supernatants. Eluted protein was then filtered through a 0.22 μm spin-column filter (1 min, 4,000 rcf, 4 °C) before loading onto a Superdex 200 Increase 10/300 GL (Cytiva) gel filtration column equilibrated with 20 mM HEPES-NaOH, pH 7.5, 200 mM NaCl, 5% glycerol using an Äkta pure protein purification system (Cytiva). The peak fraction was collected, concentration measured by NanoDrop, and protein aliquoted and snap frozen in liquid nitrogen prior to storage at –80 °C.</p></sec><sec id="s4-7"><title>Hydrogen-deuterium exchange and mass spectrometry (HDX-MS)</title><p>All HDX data were collected using LEAP HDX automation (Trajan). A 5 μL volume of freshly purified EFR<sup>WT</sup> or EFR<sup>Y836F</sup> at 0.3–0.6 mg/ml in 20 mM HEPES-NaOH, pH 7.2, 150 mM NaCl (5 μl) was labeled by 20-fold dilution with 20 mM HEPES-NaOH, pD 7.4, 100 mM NaCl at 25 ºC. The labeled sample was quenched at different time points (10, 60, 600, 3600, and 7200 s) by adding 100 μl of cold 200 mM glycine buffer (pH 2.3). A fully-deuterated sample was also prepared by labeling the protein sample for 1 min with 20 mM HEPES-NaOH, pD 7.4, 100 mM NaCl, 8 M urea-d4 (Cambridge Isotope Laboratories, Inc). The quenched sample was immediately injected onto an Enzymate BEH pepsin column (Waters) at 2 ºC, and the labeled sample was digested for 3 min. The peptic peptides were trapped and separated using an Acquity UPLC BEH C18 pre-column (2.1x5 mm, 1.7 μm, Waters) and Acquity UPLC BEH C18 column (1.0x100 mm, 1.7 μm, Waters), respectively, using a linear gradient of 5 to 40% acetonitrile over 7 min. The MS<sup>e</sup> data were acquired on a Synapt G2-Si (Waters) using 0.5 s scan time and ramp collision energy of 5 V to 10 V for LE and 15 V to 40 V for HE with continuous lock mass (Leu-Enk) for the mass accuracy correction.</p></sec><sec id="s4-8"><title>HDX-MS data analysis</title><p>Peptides were sequenced using ProteinLynx Global Server 3.03 (PLGS, Waters), and the deuterium uptake of each peptic peptides was determined using DynamX 3.0 (Waters). The deuterium uptake of all analyzed peptides presented in this study is the average uptake of three biological replicates with technical triplicates per biological sample. The percent exchange of each peptic peptide (%D) was calculated by the following equation:<disp-formula id="equ1"><mml:math id="m1"><mml:mi>%</mml:mi><mml:mi>E</mml:mi><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>∙</mml:mo><mml:mn>100</mml:mn></mml:math></disp-formula></p><p>where m<sub>t</sub> = the centroid mass of a peptic peptide at time, t, m<sub>0</sub>=the centroid mass of a peptic peptide without deuterium labeling, and m<sub>f</sub> = the centroid mass of a peptic peptide for the fully-deuterated standard sample. The Student’s t-test of the HDX data was calculated, as described previously (<xref ref-type="bibr" rid="bib19">Houde et al., 2011</xref>), by using the average of standard deviations of the percent exchange data of all analyzed peptides from n=3 biological experiments. All data were collected and analyzed according to consensus HDX-MS guidelines (<xref ref-type="bibr" rid="bib38">Masson et al., 2019</xref>). A summary of HDX-MS data is presented in <xref ref-type="table" rid="table3">Table 3</xref>; <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Summary table of HDX-MS analysis.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Data Set</th><th align="left" valign="bottom">Wild-type EFR</th><th align="left" valign="bottom">EFR<sup>Y836F</sup></th></tr></thead><tbody><tr><td align="left" valign="bottom">HDX reaction details</td><td align="left" valign="bottom">20 mM HEPES, 100 mM NaCl, pD 7.4</td><td align="left" valign="bottom">20 mM HEPES, 100 mM NaCl, pD 7.4</td></tr><tr><td align="left" valign="bottom">HDX time course</td><td align="left" valign="bottom">0, 10, 60, 600, 3600, and 7200 s</td><td align="left" valign="bottom">0, 10, 60, 600, 3600, and 7200 s</td></tr><tr><td align="left" valign="bottom">HDX control samples</td><td align="left" valign="bottom">8 M urea-D4 for fully deuterated standard</td><td align="left" valign="bottom">8 M urea-D4 for fully deuterated standard</td></tr><tr><td align="left" valign="bottom">Back-exchange</td><td align="left" valign="bottom">46%</td><td align="left" valign="bottom">49%</td></tr><tr><td align="left" valign="bottom"># of Peptides</td><td align="left" valign="bottom">143</td><td align="left" valign="bottom">153</td></tr><tr><td align="left" valign="bottom">Sequence coverage</td><td align="left" valign="bottom">100%</td><td align="left" valign="bottom">100%</td></tr><tr><td align="left" valign="bottom">Ave peptide length / Redundancy</td><td align="left" valign="bottom">12.7/5.44</td><td align="left" valign="bottom">13.3/6.06</td></tr><tr><td align="left" valign="bottom">Replicates</td><td align="left" valign="bottom">n=3 biological repeats (3 technical/n)</td><td align="left" valign="bottom">n=3 biological repeats (3 technical/n)</td></tr><tr><td align="left" valign="bottom">Repeatability (Ave SD)</td><td align="left" valign="bottom">0.129 Da (2.28 %)</td><td align="left" valign="bottom">0.111 Da (2.09 %)</td></tr><tr><td align="left" valign="bottom">Significant differences in HDX (98% CL)</td><td align="left" valign="bottom" colspan="2">0.395 Da (7.18 %)</td></tr></tbody></table></table-wrap><sec id="s4-8-1"><title><sc>I</sc>n vitro kinase assay</title><p>Aliquots of purified protein stored at –80 °C were thawed in a water bath at room temperature and then kept on ice. Protein concentrations were determined by measuring the absorption at 280 nm using a Nanodrop 1000 Spectrophotometer (ThermoScientific) and calculating the concentration using the computed extinction coefficient under reducing conditions (Expasy Protparam, <xref ref-type="table" rid="table4">Table 4</xref>) of the respective protein. Kinase reactions were performed with 50 nM of each kinase in a total reaction volume of 20 μl containing 20 mM HEPES-NaOH, pH 7.2, 2.5 mM MgCl<sub>2</sub>, 2.5 mM MnCl<sub>2</sub>, 1 mM DTT, 100 μM ATP, and 0.5 μCi <sup>32</sup>γP-ATP. A total of 500 nM of 6xHis-TEV-BIK1 D202N was also added to the reaction mixture. The reaction was stopped after 10 min by adding 5 μl 6 x SDS-loading buffer (300 mM Tris, pH6.8, 30% (v/v) glycerol, 6% (w/v) SDS, 0.05% (w/v) bromophenol blue), and heating the sample at 70 °C for 10 min. Subsequently, 20 μl of the sample was loaded onto a 10% SDS-PAGE gel and protein separated by electrophoresis at 130 V for 60–70 min. Proteins were then transferred to a PVDF membrane at a current of 200 mA over 2 hr. Membranes were stained with CBBG250 for 20 s and destaining (45% methanol (v/v), 10% acetic acid (v/v)) for 10 min. Finally, a phosphor-screen was exposed to the PVDF membrane overnight and imaged using an Amersham Typhoon (GE Lifesciences). Band intensities were quantified using ImageQuant software (GE Lifesciences) with background subtraction using the local median method.</p><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>Extinction coefficients and molecular weights retrieved from ProtParam and used for determination of protein concentration.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Protein</th><th align="left" valign="bottom">Extinction coefficient (reduced state)[Abs 0.1% (=1 g/l)]</th><th align="left" valign="bottom">Molecular weight[kDa]</th></tr></thead><tbody><tr><td align="left" valign="bottom">FKBP-EFR-mEGFP</td><td align="char" char="." valign="bottom">7.40</td><td align="char" char="." valign="bottom">80</td></tr><tr><td align="left" valign="bottom">FKBP-BRI1-mEGFP</td><td align="char" char="." valign="bottom">8.26</td><td align="char" char="." valign="bottom">83</td></tr><tr><td align="left" valign="bottom">FKBP-FLS2-mEGFP</td><td align="char" char="." valign="bottom">6.56</td><td align="char" char="." valign="bottom">79</td></tr><tr><td align="left" valign="bottom">FKBP-XIIa5-mEGFP</td><td align="char" char="." valign="bottom">7.59</td><td align="char" char="." valign="bottom">79.5</td></tr><tr><td align="left" valign="bottom">FRB-BAK1</td><td align="char" char="." valign="bottom">15.07</td><td align="char" char="." valign="bottom">55</td></tr><tr><td align="left" valign="bottom">6xHis-TEV-BIK1<sup>D202N</sup></td><td align="char" char="." valign="bottom">9.45</td><td align="char" char="." valign="bottom">47</td></tr><tr><td align="char" char="hyphen" valign="bottom">6xHis-TEV-EFR(684–1031)</td><td align="char" char="." valign="bottom">6.97</td><td align="char" char="." valign="bottom">41.5</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4-9"><title>IP-kinase assay/co-immunoprecipitation</title><p>Forty microliters of a 50%-slurry of GFP-Trap agarose-beads (ChromoTek) per sample were equilibrated, first with 1 ml water and then twice with 1 ml extraction buffer. Beads were then prepared as a 50% slurry in extraction buffer, and 40 μl were added to each protein extract prepared as described above. Beads were incubated with the extract for 2 hr at 4 °C on a rotator. Beads were then washed four times with 1 ml extraction buffer and split into halves at the last washing step. To one half, 20 μl 2 x SDS-loading buffer was added, and the sample heated for 5 min at 95 °C. The other half was equilibrated with 500 μl kinase reaction buffer (20 mM HEPES, pH 7.2, 5% glycerol, 100 mM NaCl). After pelleting the beads, the supernatant was aspirated and 20 μl of kinase reaction buffer containing additionally 2.5 mM MgCl<sub>2</sub>, 2.5 mM MnCl<sub>2</sub>, 100 μM ATP, 1 μCi <sup>32</sup>γP-ATP and 0.5 μM 6xHis-BIK1 D202N were added to each sample. Kinase reactions were incubated at 30 °C for 30 min with 800 rpm shaking and were stopped by adding 5 μl 6 x SDS-loading dye and heating at 70 °C for 10 min. Subsequent steps were performed as described for in vitro kinase assays.</p></sec><sec id="s4-10"><title>SDS-PAGE and western blotting</title><p>SDS containing gels were prepared manually. The resolving gel buffer contained 0.375 M Tris base, 0.4% SDS, pH 8.8, 10–12% acrylamide (37.5:1 acrylamide:bisacrylamide ratio), and the stacking gel buffer contained 0.125 M Tris base, 0.4% SDS, pH 6.8, 5% acrylamide (37.5:1 acrlyamid:bisacrylamide ratio). Polymerization was induced by addition of 1 mg/ml ammonium persulfate and 1:2000 TEMED in case of the resolving gel or 1:1000 TEMED for the stacking gel.</p><p>Protein samples were mixed with 6 x SDS loading dye (300 mM Tris, pH 6.8, 30% glycerol, 6% SDS, 0.05% bromophenol blue) and DTT was added to a final concentration of 100 mM. Samples were heated to 80–90°C for 5–10 min prior to loading the gel. Electrophoresis, with gels being submerged in SDS running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) was performed at 120–200 V until the dye front reached the bottom of the gel.</p><p>Subsequently, proteins were transferred onto PVDF membranes using wet transfer. For this, the transfer stack was assembled fully submerged in transfer buffer (25 mM Tris base, 192 mM glycine, 20% MeOH). Transfer was performed at 100 V for 90 min in the cold room (4 °C) with an additional ice pack in the casket. Membranes were subsequently blocked with 5% skim milk powder dissolved in Tris buffered saline containing Tween-20 (TBS-T; 20 mM Tris base, pH 7.5, 150 mM NaCl, 0.1% Tween-20) for at least 2 hr. The primary antibody was then added (refer to Key Resources Table for conditions) and binding allowed overnight on a shaker at 4 °C. The next day, membranes were washed four times with TBS-T for 10 min each, before adding secondary antibody for at least 2 h. Membranes were then washed three times for 5 min each with TBS-T, and a fourth time with TBS.</p><p>Immunoblots were visualized using chemiluminescence. SuperSignal West Femto Maximum Sensitivity Substrate was prepared according to the manufacturer’s manual and distributed equally over a transparent film. The membrane was rolled over the substrate to allow equal distribution of substrate on the membrane.</p></sec><sec id="s4-11"><title>Structure prediction and analysis</title><p>Structures of the isolated EFR kinase domain or the intracellular domain were predicted using AlphaFold2 (<xref ref-type="bibr" rid="bib22">Jumper et al., 2021</xref>) running it in Google CoLab (<xref ref-type="bibr" rid="bib42">Mirdita et al., 2022</xref>). PDB files were downloaded and the best model (highest pLDDT score) was visualized in ChimeraX 1.6 (<xref ref-type="bibr" rid="bib50">Pettersen et al., 2021</xref>). Hydrogen bonds were predicted in ChimeraX which uses angle and distance cutoffs for H-bonds described in <xref ref-type="bibr" rid="bib40">Mills and Dean, 1996</xref>.</p></sec><sec id="s4-12"><title>Phylogenetic analysis and tree visualization</title><p>Multiple sequence alignments were retrieved from a previous phylogenetic study of plant LRR-RKs (<xref ref-type="bibr" rid="bib11">Dufayard et al., 2017</xref>). Specifically, the trimmed multiple sequence alignment for subfamily XIIa was retrieved. The retrieved MSA was used for building a phylogenetic tree using the IQ-TREE webserver (<xref ref-type="bibr" rid="bib23">Kalyaanamoorthy et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Minh et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Trifinopoulos et al., 2016</xref>). The generated tree file was then used to visualize the tree in R using the ggtree package v3.8.2 (<xref ref-type="bibr" rid="bib74">Yu et al., 2017</xref>).</p></sec><sec id="s4-13"><title>Statistical analysis</title><p>In general, non-parametric Kruskal-Wallis tests with Dunn’s post-hoc test (Benjamin-Hochberg correction) where applied in this study because either sample size were small, data was not normally distributed or variance between groups were not similar. Outliers shown in boxplots were not removed prior to statistical analysis.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Supervision, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-92110-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All HDX RAW data for wild type and Y836F EFR have been deposited to the ProteomeXchange Consortium via ProteomeXchage via the PRIDE (<xref ref-type="bibr" rid="bib48">Perez-Riverol et al., 2022</xref>) with the dataset identifier PXD049215. Supplemental information, including plasmid maps, replication information, cropping information, gene IDs, protein sequences, and PDB files, are available through a Zenodo repository (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.10577812">https://doi.org/10.5281/zenodo.10577812</ext-link>).</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Tsutsui</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling</data-title><source>PRIDE</source><pub-id pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/pride/archive/projects/PXD049215">PXD049215</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Mühlenbeck</surname><given-names>H</given-names></name><name><surname>Tsutsui</surname><given-names>Y</given-names></name><name><surname>Lemmon</surname><given-names>MA</given-names></name><name><surname>Bender</surname><given-names>KW</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Supplemental Information - Allosteric activation of the co-receptor BAK1 by the EFR receptor kinase initiates immune signaling</data-title><source>Zenodo</source><pub-id pub-id-type="doi">10.5281/zenodo.10577812</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Tamaryn Ellick for plant care, Ursin Stirnemann for help establishing the Rap-induced dimerization work, and Fabian Lachmann for help with preparative tasks. Further, we thank Jeonghayng Park, Eunkyoo Oh and Jungmook Kim for sharing materials of and information about the Rap-induced dimerization system. All past and current members of the Zipfel group are thanked for fruitful discussions. This project was funded by the University of Zürich (C.Z.), the Swiss National Science Foundation grant no. 31003 A_182625 (C.Z.), a joint European Research Area Network for Coordinating Action in Plant Sciences (ERA-CAPS) grant (‘SICOPID’) from UK Research and Innovation (BB/S004734/1) (C.Z.), and by NIH grant R35-GM122485 (M.A.L.).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albrecht</surname><given-names>C</given-names></name><name><surname>Russinova</surname><given-names>E</given-names></name><name><surname>Kemmerling</surname><given-names>B</given-names></name><name><surname>Kwaaitaal</surname><given-names>M</given-names></name><name><surname>de Vries</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Arabidopsis somatic embryogenesis receptor kinase proteins serve brassinosteroid-dependent and -independent signaling pathways</article-title><source>Plant Physiology</source><volume>148</volume><fpage>611</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1104/pp.108.123216</pub-id><pub-id pub-id-type="pmid">18667726</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banaszynski</surname><given-names>LA</given-names></name><name><surname>Liu</surname><given-names>CW</given-names></name><name><surname>Wandless</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Characterization of the FKBP.rapamycin.FRB ternary complex</article-title><source>Journal of the American Chemical Society</source><volume>127</volume><fpage>4715</fpage><lpage>4721</lpage><pub-id pub-id-type="doi">10.1021/ja043277y</pub-id><pub-id pub-id-type="pmid">15796538</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname><given-names>KW</given-names></name><name><surname>Couto</surname><given-names>D</given-names></name><name><surname>Kadota</surname><given-names>Y</given-names></name><name><surname>Macho</surname><given-names>AP</given-names></name><name><surname>Sklenar</surname><given-names>J</given-names></name><name><surname>Derbyshire</surname><given-names>P</given-names></name><name><surname>Bjornson</surname><given-names>M</given-names></name><name><surname>DeFalco</surname><given-names>TA</given-names></name><name><surname>Petriello</surname><given-names>A</given-names></name><name><surname>Font Farre</surname><given-names>M</given-names></name><name><surname>Schwessinger</surname><given-names>B</given-names></name><name><surname>Ntoukakis</surname><given-names>V</given-names></name><name><surname>Stransfeld</surname><given-names>L</given-names></name><name><surname>Jones</surname><given-names>AME</given-names></name><name><surname>Menke</surname><given-names>FLH</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Activation loop phosphorylation of a non-RD receptor kinase initiates plant innate immune signaling</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2108242118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2108242118</pub-id><pub-id pub-id-type="pmid">34531323</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname><given-names>KW</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Paradigms of receptor kinase signaling in plants</article-title><source>The Biochemical Journal</source><volume>480</volume><fpage>835</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1042/BCJ20220372</pub-id><pub-id pub-id-type="pmid">37326386</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Aceti</surname><given-names>DJ</given-names></name><name><surname>Sabat</surname><given-names>G</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Makino</surname><given-names>SI</given-names></name><name><surname>Fox</surname><given-names>BG</given-names></name><name><surname>Bent</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mutations in FLS2 Ser-938 dissect signaling activation in FLS2-mediated Arabidopsis immunity</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003313</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003313</pub-id><pub-id pub-id-type="pmid">23637603</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiasson</surname><given-names>D</given-names></name><name><surname>Giménez-Oya</surname><given-names>V</given-names></name><name><surname>Bircheneder</surname><given-names>M</given-names></name><name><surname>Bachmaier</surname><given-names>S</given-names></name><name><surname>Studtrucker</surname><given-names>T</given-names></name><name><surname>Ryan</surname><given-names>J</given-names></name><name><surname>Sollweck</surname><given-names>K</given-names></name><name><surname>Leonhardt</surname><given-names>H</given-names></name><name><surname>Boshart</surname><given-names>M</given-names></name><name><surname>Dietrich</surname><given-names>P</given-names></name><name><surname>Parniske</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A unified multi-kingdom golden gate cloning platform</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>10131</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-46171-2</pub-id><pub-id pub-id-type="pmid">31300661</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clough</surname><given-names>SJ</given-names></name><name><surname>Bent</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Floral dip: a simplified method for agrobacterium-mediated transformation of <italic>Arabidopsis thaliana</italic></article-title><source>The Plant Journal</source><volume>16</volume><fpage>735</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1046/j.1365-313x.1998.00343.x</pub-id><pub-id pub-id-type="pmid">10069079</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couto</surname><given-names>D</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulation of pattern recognition receptor signalling in plants</article-title><source>Nature Reviews. Immunology</source><volume>16</volume><fpage>537</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.77</pub-id><pub-id pub-id-type="pmid">27477127</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>AM</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name><name><surname>Millar</surname><given-names>AJ</given-names></name><name><surname>Darrah</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Protocol: streamlined sub-protocols for floral-dip transformation and selection of transformants in <italic>Arabidopsis thaliana</italic></article-title><source>Plant Methods</source><volume>5</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1186/1746-4811-5-3</pub-id><pub-id pub-id-type="pmid">19250520</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFalco</surname><given-names>TA</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular mechanisms of early plant pattern-triggered immune signaling</article-title><source>Molecular Cell</source><volume>81</volume><fpage>3449</fpage><lpage>3467</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.07.029</pub-id><pub-id pub-id-type="pmid">34403694</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dufayard</surname><given-names>JF</given-names></name><name><surname>Bettembourg</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>I</given-names></name><name><surname>Droc</surname><given-names>G</given-names></name><name><surname>Guiderdoni</surname><given-names>E</given-names></name><name><surname>Périn</surname><given-names>C</given-names></name><name><surname>Chantret</surname><given-names>N</given-names></name><name><surname>Diévart</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>New insights on leucine-rich repeats receptor-like kinase orthologous relationships in angiosperms</article-title><source>Frontiers in Plant Science</source><volume>8</volume><elocation-id>381</elocation-id><pub-id pub-id-type="doi">10.3389/fpls.2017.00381</pub-id><pub-id pub-id-type="pmid">28424707</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eyers</surname><given-names>PA</given-names></name><name><surname>Murphy</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dawn of the dead: protein pseudokinases signal new adventures in cell biology</article-title><source>Biochemical Society Transactions</source><volume>41</volume><fpage>969</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1042/BST20130115</pub-id><pub-id pub-id-type="pmid">23863165</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Faezov</surname><given-names>B</given-names></name><name><surname>Dunbrack</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Alphafold2 models of the active form of all 437 catalytically competent human protein kinase domains</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.07.21.550125</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>SA</given-names></name><name><surname>Whalen</surname><given-names>DM</given-names></name><name><surname>Özen</surname><given-names>A</given-names></name><name><surname>Wongchenko</surname><given-names>MJ</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Yen</surname><given-names>I</given-names></name><name><surname>Schaefer</surname><given-names>G</given-names></name><name><surname>Mayfield</surname><given-names>JD</given-names></name><name><surname>Chmielecki</surname><given-names>J</given-names></name><name><surname>Stephens</surname><given-names>PJ</given-names></name><name><surname>Albacker</surname><given-names>LA</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Hatzivassiliou</surname><given-names>G</given-names></name><name><surname>Eigenbrot</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Shaw</surname><given-names>AS</given-names></name><name><surname>Manning</surname><given-names>G</given-names></name><name><surname>Skelton</surname><given-names>NJ</given-names></name><name><surname>Hymowitz</surname><given-names>SG</given-names></name><name><surname>Malek</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Activation mechanism of oncogenic deletion mutations in BRAF, EGFR, and HER2</article-title><source>Cancer Cell</source><volume>29</volume><fpage>477</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.02.010</pub-id><pub-id pub-id-type="pmid">26996308</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez-Gómez</surname><given-names>L</given-names></name><name><surname>Boller</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>FLS2: an LRR receptor-like kinase involved in the perception of the bacterial elicitor flagellin in <italic>Arabidopsis</italic></article-title><source>Molecular Cell</source><volume>5</volume><fpage>1003</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(00)80265-8</pub-id><pub-id pub-id-type="pmid">10911994</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>ZY</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Lamb</surname><given-names>C</given-names></name><name><surname>Ronald</surname><given-names>P</given-names></name><name><surname>Chory</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Perception of brassinosteroids by the extracellular domain of the receptor kinase BRI1</article-title><source>Science</source><volume>288</volume><fpage>2360</fpage><lpage>2363</lpage><pub-id pub-id-type="doi">10.1126/science.288.5475.2360</pub-id><pub-id pub-id-type="pmid">10875920</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hohmann</surname><given-names>U</given-names></name><name><surname>Lau</surname><given-names>K</given-names></name><name><surname>Hothorn</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The structural basis of ligand perception and signal activation by receptor kinases</article-title><source>Annual Review of Plant Biology</source><volume>68</volume><fpage>109</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1146/annurev-arplant-042916-040957</pub-id><pub-id pub-id-type="pmid">28125280</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hothorn</surname><given-names>M</given-names></name><name><surname>Belkhadir</surname><given-names>Y</given-names></name><name><surname>Dreux</surname><given-names>M</given-names></name><name><surname>Dabi</surname><given-names>T</given-names></name><name><surname>Noel</surname><given-names>JP</given-names></name><name><surname>Wilson</surname><given-names>IA</given-names></name><name><surname>Chory</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structural basis of steroid hormone perception by the receptor kinase BRI1</article-title><source>Nature</source><volume>474</volume><fpage>467</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1038/nature10153</pub-id><pub-id pub-id-type="pmid">21666665</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houde</surname><given-names>D</given-names></name><name><surname>Berkowitz</surname><given-names>SA</given-names></name><name><surname>Engen</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies</article-title><source>Journal of Pharmaceutical Sciences</source><volume>100</volume><fpage>2071</fpage><lpage>2086</lpage><pub-id pub-id-type="doi">10.1002/jps.22432</pub-id><pub-id pub-id-type="pmid">21491437</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Stites</surname><given-names>EC</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Germino</surname><given-names>EA</given-names></name><name><surname>Meharena</surname><given-names>HS</given-names></name><name><surname>Stork</surname><given-names>PJS</given-names></name><name><surname>Kornev</surname><given-names>AP</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Shaw</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Allosteric activation of functionally asymmetric RAF kinase dimers</article-title><source>Cell</source><volume>154</volume><fpage>1036</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.07.046</pub-id><pub-id pub-id-type="pmid">23993095</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Ahuja</surname><given-names>LG</given-names></name><name><surname>Meharena</surname><given-names>HS</given-names></name><name><surname>Kannan</surname><given-names>N</given-names></name><name><surname>Kornev</surname><given-names>AP</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Shaw</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Kinase regulation by hydrophobic spine assembly in cancer</article-title><source>Molecular and Cellular Biology</source><volume>35</volume><fpage>264</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1128/MCB.00943-14</pub-id><pub-id pub-id-type="pmid">25348715</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Kohl</surname><given-names>SAA</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Romera-Paredes</surname><given-names>B</given-names></name><name><surname>Nikolov</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Back</surname><given-names>T</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Reiman</surname><given-names>D</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Pacholska</surname><given-names>M</given-names></name><name><surname>Berghammer</surname><given-names>T</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Silver</surname><given-names>D</given-names></name><name><surname>Vinyals</surname><given-names>O</given-names></name><name><surname>Senior</surname><given-names>AW</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalyaanamoorthy</surname><given-names>S</given-names></name><name><surname>Minh</surname><given-names>BQ</given-names></name><name><surname>Wong</surname><given-names>TKF</given-names></name><name><surname>von Haeseler</surname><given-names>A</given-names></name><name><surname>Jermiin</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ModelFinder: fast model selection for accurate phylogenetic estimates</article-title><source>Nature Methods</source><volume>14</volume><fpage>587</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4285</pub-id><pub-id pub-id-type="pmid">28481363</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Jeon</surname><given-names>BW</given-names></name><name><surname>Hwang</surname><given-names>G</given-names></name><name><surname>Kang</surname><given-names>NY</given-names></name><name><surname>We</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>WY</given-names></name><name><surname>Oh</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Chemical control of receptor kinase signaling by rapamycin-induced dimerization</article-title><source>Molecular Plant</source><volume>14</volume><fpage>1379</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1016/j.molp.2021.05.006</pub-id><pub-id pub-id-type="pmid">33964457</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosentka</surname><given-names>PZ</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Simon</surname><given-names>YA</given-names></name><name><surname>Satpathy</surname><given-names>B</given-names></name><name><surname>Maradiaga</surname><given-names>R</given-names></name><name><surname>Mitoubsi</surname><given-names>O</given-names></name><name><surname>Shpak</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Identification of critical functional residues of receptor-like kinase ERECTA</article-title><source>Journal of Experimental Botany</source><volume>68</volume><fpage>1507</fpage><lpage>1518</lpage><pub-id pub-id-type="doi">10.1093/jxb/erx022</pub-id><pub-id pub-id-type="pmid">28207053</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>A</given-names></name><name><surname>Scott</surname><given-names>S</given-names></name><name><surname>Taujale</surname><given-names>R</given-names></name><name><surname>Yeung</surname><given-names>W</given-names></name><name><surname>Kochut</surname><given-names>KJ</given-names></name><name><surname>Eyers</surname><given-names>PA</given-names></name><name><surname>Kannan</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tracing the origin and evolution of pseudokinases across the tree of life</article-title><source>Science Signaling</source><volume>12</volume><elocation-id>eaav3810</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aav3810</pub-id><pub-id pub-id-type="pmid">31015289</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>S</given-names></name><name><surname>Safaei</surname><given-names>J</given-names></name><name><surname>Pelech</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Evolutionary ancestry of eukaryotic protein kinases and choline kinases</article-title><source>The Journal of Biological Chemistry</source><volume>291</volume><fpage>5199</fpage><lpage>5205</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.691428</pub-id><pub-id pub-id-type="pmid">26742849</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmon</surname><given-names>MA</given-names></name><name><surname>Schlessinger</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cell signaling by receptor tyrosine kinases</article-title><source>Cell</source><volume>141</volume><fpage>1117</fpage><lpage>1134</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.06.011</pub-id><pub-id pub-id-type="pmid">20602996</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The FLS2-associated kinase BIK1 directly phosphorylates the NADPH oxidase RbohD to control plant immunity</article-title><source>Cell Host &amp; Microbe</source><volume>15</volume><fpage>329</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.02.009</pub-id><pub-id pub-id-type="pmid">24629339</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>D</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Mengiste</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>P</given-names></name><name><surname>Shan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Inverse modulation of plant immune and brassinosteroid signaling pathways by the receptor-like cytoplasmic kinase BIK1</article-title><source>PNAS</source><volume>110</volume><fpage>12114</fpage><lpage>12119</lpage><pub-id pub-id-type="doi">10.1073/pnas.1302154110</pub-id><pub-id pub-id-type="pmid">23818580</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Naismith</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol</article-title><source>BMC Biotechnology</source><volume>8</volume><elocation-id>91</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6750-8-91</pub-id><pub-id pub-id-type="pmid">19055817</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Gong</surname><given-names>BQ</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Xiong</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Feng</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>JF</given-names></name><name><surname>Wang</surname><given-names>HB</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Tyrosine phosphorylation cycle regulates fungal activation of a plant receptor ser/thr kinase</article-title><source>Cell Host &amp; Microbe</source><volume>23</volume><fpage>241</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2017.12.005</pub-id><pub-id pub-id-type="pmid">29396039</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Shan</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A receptor-like cytoplasmic kinase, BIK1, associates with a flagellin receptor complex to initiate plant innate immunity</article-title><source>PNAS</source><volume>107</volume><fpage>496</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1073/pnas.0909705107</pub-id><pub-id pub-id-type="pmid">20018686</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zou</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tyrosine phosphorylation of the lectin receptor-like kinase LORE regulates plant immunity</article-title><source>The EMBO Journal</source><volume>39</volume><elocation-id>e102856</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2019102856</pub-id><pub-id pub-id-type="pmid">31922267</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mace</surname><given-names>PD</given-names></name><name><surname>Murphy</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>There’s more to death than life: noncatalytic functions in kinase and pseudokinase signaling</article-title><source>The Journal of Biological Chemistry</source><volume>296</volume><elocation-id>100705</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2021.100705</pub-id><pub-id pub-id-type="pmid">33895136</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macho</surname><given-names>AP</given-names></name><name><surname>Schwessinger</surname><given-names>B</given-names></name><name><surname>Ntoukakis</surname><given-names>V</given-names></name><name><surname>Brutus</surname><given-names>A</given-names></name><name><surname>Segonzac</surname><given-names>C</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Kadota</surname><given-names>Y</given-names></name><name><surname>Oh</surname><given-names>MH</given-names></name><name><surname>Sklenar</surname><given-names>J</given-names></name><name><surname>Derbyshire</surname><given-names>P</given-names></name><name><surname>Lozano-Durán</surname><given-names>R</given-names></name><name><surname>Malinovsky</surname><given-names>FG</given-names></name><name><surname>Monaghan</surname><given-names>J</given-names></name><name><surname>Menke</surname><given-names>FL</given-names></name><name><surname>Huber</surname><given-names>SC</given-names></name><name><surname>He</surname><given-names>SY</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A bacterial tyrosine phosphatase inhibits plant pattern recognition receptor activation</article-title><source>Science</source><volume>343</volume><fpage>1509</fpage><lpage>1512</lpage><pub-id pub-id-type="doi">10.1126/science.1248849</pub-id><pub-id pub-id-type="pmid">24625928</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>J</given-names></name><name><surname>Harrington</surname><given-names>T</given-names></name><name><surname>Lally</surname><given-names>K</given-names></name><name><surname>Bartlett</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Asymmetric evolution of protein domains in the leucine-rich repeat receptor-like kinase (lrr-rlk) family of plant developmental coordinators</article-title><source>Plant Biology</source><volume>01</volume><elocation-id>e2436</elocation-id><pub-id pub-id-type="doi">10.1101/2023.03.13.532436</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masson</surname><given-names>GR</given-names></name><name><surname>Burke</surname><given-names>JE</given-names></name><name><surname>Ahn</surname><given-names>NG</given-names></name><name><surname>Anand</surname><given-names>GS</given-names></name><name><surname>Borchers</surname><given-names>C</given-names></name><name><surname>Brier</surname><given-names>S</given-names></name><name><surname>Bou-Assaf</surname><given-names>GM</given-names></name><name><surname>Engen</surname><given-names>JR</given-names></name><name><surname>Englander</surname><given-names>SW</given-names></name><name><surname>Faber</surname><given-names>J</given-names></name><name><surname>Garlish</surname><given-names>R</given-names></name><name><surname>Griffin</surname><given-names>PR</given-names></name><name><surname>Gross</surname><given-names>ML</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Hamuro</surname><given-names>Y</given-names></name><name><surname>Heck</surname><given-names>AJR</given-names></name><name><surname>Houde</surname><given-names>D</given-names></name><name><surname>Iacob</surname><given-names>RE</given-names></name><name><surname>Jørgensen</surname><given-names>TJD</given-names></name><name><surname>Kaltashov</surname><given-names>IA</given-names></name><name><surname>Klinman</surname><given-names>JP</given-names></name><name><surname>Konermann</surname><given-names>L</given-names></name><name><surname>Man</surname><given-names>P</given-names></name><name><surname>Mayne</surname><given-names>L</given-names></name><name><surname>Pascal</surname><given-names>BD</given-names></name><name><surname>Reichmann</surname><given-names>D</given-names></name><name><surname>Skehel</surname><given-names>M</given-names></name><name><surname>Snijder</surname><given-names>J</given-names></name><name><surname>Strutzenberg</surname><given-names>TS</given-names></name><name><surname>Underbakke</surname><given-names>ES</given-names></name><name><surname>Wagner</surname><given-names>C</given-names></name><name><surname>Wales</surname><given-names>TE</given-names></name><name><surname>Walters</surname><given-names>BT</given-names></name><name><surname>Weis</surname><given-names>DD</given-names></name><name><surname>Wilson</surname><given-names>DJ</given-names></name><name><surname>Wintrode</surname><given-names>PL</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Schriemer</surname><given-names>DC</given-names></name><name><surname>Rand</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments</article-title><source>Nature Methods</source><volume>16</volume><fpage>595</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0459-y</pub-id><pub-id pub-id-type="pmid">31249422</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meharena</surname><given-names>HS</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Ahuja</surname><given-names>LG</given-names></name><name><surname>Keshwani</surname><given-names>MM</given-names></name><name><surname>McClendon</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>AM</given-names></name><name><surname>Adams</surname><given-names>JA</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Decoding the interactions regulating the active state mechanics of eukaryotic protein kinases</article-title><source>PLOS Biology</source><volume>14</volume><elocation-id>e2000127</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2000127</pub-id><pub-id pub-id-type="pmid">27902690</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>JE</given-names></name><name><surname>Dean</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Three-dimensional hydrogen-bond geometry and probability information from a crystal survey</article-title><source>Journal of Computer-Aided Molecular Design</source><volume>10</volume><fpage>607</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1007/BF00134183</pub-id><pub-id pub-id-type="pmid">9007693</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minh</surname><given-names>BQ</given-names></name><name><surname>Schmidt</surname><given-names>HA</given-names></name><name><surname>Chernomor</surname><given-names>O</given-names></name><name><surname>Schrempf</surname><given-names>D</given-names></name><name><surname>Woodhams</surname><given-names>MD</given-names></name><name><surname>von Haeseler</surname><given-names>A</given-names></name><name><surname>Lanfear</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era</article-title><source>Molecular Biology and Evolution</source><volume>37</volume><fpage>1530</fpage><lpage>1534</lpage><pub-id pub-id-type="doi">10.1093/molbev/msaa015</pub-id><pub-id pub-id-type="pmid">32011700</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>Schütze</surname><given-names>K</given-names></name><name><surname>Moriwaki</surname><given-names>Y</given-names></name><name><surname>Heo</surname><given-names>L</given-names></name><name><surname>Ovchinnikov</surname><given-names>S</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Colabfold: making protein folding accessible to all bioinformatics</article-title><source>Nature Methods</source><volume>01</volume><fpage>679</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/s41592-022-01488-1</pub-id><pub-id pub-id-type="pmid">35637307</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffett</surname><given-names>AS</given-names></name><name><surname>Bender</surname><given-names>KW</given-names></name><name><surname>Huber</surname><given-names>SC</given-names></name><name><surname>Shukla</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Molecular dynamics simulations reveal the conformational dynamics of <italic>Arabidopsis thaliana</italic> BRI1 and BAK1 receptor-like kinases</article-title><source>The Journal of Biological Chemistry</source><volume>292</volume><fpage>12643</fpage><lpage>12652</lpage><pub-id pub-id-type="doi">10.1074/jbc.M117.792762</pub-id><pub-id pub-id-type="pmid">28559283</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mott</surname><given-names>GA</given-names></name><name><surname>Thakur</surname><given-names>S</given-names></name><name><surname>Smakowska</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>PW</given-names></name><name><surname>Belkhadir</surname><given-names>Y</given-names></name><name><surname>Desveaux</surname><given-names>D</given-names></name><name><surname>Guttman</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genomic screens identify a new phytobacterial microbe-associated molecular pattern and the cognate <italic>Arabidopsis</italic> receptor-like kinase that mediates its immune elicitation</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>98</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0955-7</pub-id><pub-id pub-id-type="pmid">27160854</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>KH</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>BRI1/BAK1, a receptor kinase pair mediating brassinosteroid signaling</article-title><source>Cell</source><volume>110</volume><fpage>203</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(02)00814-0</pub-id><pub-id pub-id-type="pmid">12150928</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>MH</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kota</surname><given-names>U</given-names></name><name><surname>Goshe</surname><given-names>MB</given-names></name><name><surname>Clouse</surname><given-names>SD</given-names></name><name><surname>Huber</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tyrosine phosphorylation of the BRI1 receptor kinase emerges as a component of brassinosteroid signaling in <italic>Arabidopsis</italic></article-title><source>PNAS</source><volume>106</volume><fpage>658</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1073/pnas.0810249106</pub-id><pub-id pub-id-type="pmid">19124768</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Olivieri</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Walker</surname><given-names>C</given-names></name><name><surname>Subrahmanian</surname><given-names>MV</given-names></name><name><surname>Ha</surname><given-names>KN</given-names></name><name><surname>Bernlohr</surname><given-names>DA</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Camilloni</surname><given-names>C</given-names></name><name><surname>Vendruscolo</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Veglia</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The αC-Β4 loop controls the allosteric cooperativity between nucleotide and substrate in the catalytic subunit of protein kinase a biophysics</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.09.12.557419</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Riverol</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Bandla</surname><given-names>C</given-names></name><name><surname>García-Seisdedos</surname><given-names>D</given-names></name><name><surname>Hewapathirana</surname><given-names>S</given-names></name><name><surname>Kamatchinathan</surname><given-names>S</given-names></name><name><surname>Kundu</surname><given-names>DJ</given-names></name><name><surname>Prakash</surname><given-names>A</given-names></name><name><surname>Frericks-Zipper</surname><given-names>A</given-names></name><name><surname>Eisenacher</surname><given-names>M</given-names></name><name><surname>Walzer</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Brazma</surname><given-names>A</given-names></name><name><surname>Vizcaíno</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences</article-title><source>Nucleic Acids Research</source><volume>50</volume><fpage>D543</fpage><lpage>D552</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab1038</pub-id><pub-id pub-id-type="pmid">34723319</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perraki</surname><given-names>A</given-names></name><name><surname>DeFalco</surname><given-names>TA</given-names></name><name><surname>Derbyshire</surname><given-names>P</given-names></name><name><surname>Avila</surname><given-names>J</given-names></name><name><surname>Séré</surname><given-names>D</given-names></name><name><surname>Sklenar</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Stransfeld</surname><given-names>L</given-names></name><name><surname>Schwessinger</surname><given-names>B</given-names></name><name><surname>Kadota</surname><given-names>Y</given-names></name><name><surname>Macho</surname><given-names>AP</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Couto</surname><given-names>D</given-names></name><name><surname>Torii</surname><given-names>KU</given-names></name><name><surname>Menke</surname><given-names>FLH</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Phosphocode-dependent functional dichotomy of a common co-receptor in plant signalling</article-title><source>Nature</source><volume>561</volume><fpage>248</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0471-x</pub-id><pub-id pub-id-type="pmid">30177827</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><name><surname>Goddard</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Couch</surname><given-names>GS</given-names></name><name><surname>Croll</surname><given-names>TI</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>UCSF ChimeraX: structure visualization for researchers, educators, and developers</article-title><source>Protein Science</source><volume>30</volume><fpage>70</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1002/pro.3943</pub-id><pub-id pub-id-type="pmid">32881101</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranf</surname><given-names>S</given-names></name><name><surname>Eschen-Lippold</surname><given-names>L</given-names></name><name><surname>Fröhlich</surname><given-names>K</given-names></name><name><surname>Westphal</surname><given-names>L</given-names></name><name><surname>Scheel</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Microbe-associated molecular pattern-induced calcium signaling requires the receptor-like cytoplasmic kinases, PBL1 and BIK1</article-title><source>BMC Plant Biology</source><volume>14</volume><elocation-id>374</elocation-id><pub-id pub-id-type="doi">10.1186/s12870-014-0374-4</pub-id><pub-id pub-id-type="pmid">25522736</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Moussu</surname><given-names>S</given-names></name><name><surname>Boutrot</surname><given-names>F</given-names></name><name><surname>Santiago</surname><given-names>J</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Perception of a divergent family of phytocytokines by the Arabidopsis receptor kinase MIK2</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>705</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-20932-y</pub-id><pub-id pub-id-type="pmid">33514716</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>M</given-names></name><name><surname>Schwessinger</surname><given-names>B</given-names></name><name><surname>Albrecht</surname><given-names>C</given-names></name><name><surname>Chinchilla</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name><name><surname>Holton</surname><given-names>N</given-names></name><name><surname>Malinovsky</surname><given-names>FG</given-names></name><name><surname>Tör</surname><given-names>M</given-names></name><name><surname>de Vries</surname><given-names>S</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The Arabidopsis leucine-rich repeat receptor-like kinases BAK1/SERK3 and BKK1/SERK4 are required for innate immunity to hemibiotrophic and biotrophic pathogens</article-title><source>The Plant Cell</source><volume>23</volume><fpage>2440</fpage><lpage>2455</lpage><pub-id pub-id-type="doi">10.1105/tpc.111.084301</pub-id><pub-id pub-id-type="pmid">21693696</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago</surname><given-names>J</given-names></name><name><surname>Henzler</surname><given-names>C</given-names></name><name><surname>Hothorn</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular mechanism for plant steroid receptor activation by somatic embryogenesis co-receptor kinases</article-title><source>Science</source><volume>341</volume><fpage>889</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1126/science.1242468</pub-id><pub-id pub-id-type="pmid">23929946</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>SH</given-names></name><name><surname>Weng</surname><given-names>JH</given-names></name><name><surname>Aoto</surname><given-names>PC</given-names></name><name><surname>Boassa</surname><given-names>D</given-names></name><name><surname>Mathea</surname><given-names>S</given-names></name><name><surname>Silletti</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Wallbott</surname><given-names>M</given-names></name><name><surname>Komives</surname><given-names>EA</given-names></name><name><surname>Knapp</surname><given-names>S</given-names></name><name><surname>Herberg</surname><given-names>FW</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2100844118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2100844118</pub-id><pub-id pub-id-type="pmid">34088839</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname><given-names>B</given-names></name><name><surname>Mentzel</surname><given-names>T</given-names></name><name><surname>Jehle</surname><given-names>AK</given-names></name><name><surname>Mueller</surname><given-names>K</given-names></name><name><surname>Beeler</surname><given-names>S</given-names></name><name><surname>Boller</surname><given-names>T</given-names></name><name><surname>Felix</surname><given-names>G</given-names></name><name><surname>Chinchilla</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Rapid heteromerization and phosphorylation of ligand-activated plant transmembrane receptors and their associated kinase BAK1</article-title><source>The Journal of Biological Chemistry</source><volume>285</volume><fpage>9444</fpage><lpage>9451</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.096842</pub-id><pub-id pub-id-type="pmid">20103591</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwessinger</surname><given-names>B</given-names></name><name><surname>Roux</surname><given-names>M</given-names></name><name><surname>Kadota</surname><given-names>Y</given-names></name><name><surname>Ntoukakis</surname><given-names>V</given-names></name><name><surname>Sklenar</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Phosphorylation-dependent differential regulation of plant growth, cell death, and innate immunity by the regulatory receptor-like kinase BAK1</article-title><source>PLOS Genetics</source><volume>7</volume><elocation-id>e1002046</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002046</pub-id><pub-id pub-id-type="pmid">21593986</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segonzac</surname><given-names>C</given-names></name><name><surname>Macho</surname><given-names>AP</given-names></name><name><surname>Sanmartín</surname><given-names>M</given-names></name><name><surname>Ntoukakis</surname><given-names>V</given-names></name><name><surname>Sánchez-Serrano</surname><given-names>JJ</given-names></name><name><surname>Zipfel</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Negative control of BAK1 by protein phosphatase 2A during plant innate immunity</article-title><source>The EMBO Journal</source><volume>33</volume><fpage>2069</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.15252/embj.201488698</pub-id><pub-id pub-id-type="pmid">25085430</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheetz</surname><given-names>JB</given-names></name><name><surname>Mathea</surname><given-names>S</given-names></name><name><surname>Karvonen</surname><given-names>H</given-names></name><name><surname>Malhotra</surname><given-names>K</given-names></name><name><surname>Chatterjee</surname><given-names>D</given-names></name><name><surname>Niininen</surname><given-names>W</given-names></name><name><surname>Perttilä</surname><given-names>R</given-names></name><name><surname>Preuss</surname><given-names>F</given-names></name><name><surname>Suresh</surname><given-names>K</given-names></name><name><surname>Stayrook</surname><given-names>SE</given-names></name><name><surname>Tsutsui</surname><given-names>Y</given-names></name><name><surname>Radhakrishnan</surname><given-names>R</given-names></name><name><surname>Ungureanu</surname><given-names>D</given-names></name><name><surname>Knapp</surname><given-names>S</given-names></name><name><surname>Lemmon</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural insights into pseudokinase domains of receptor tyrosine kinases</article-title><source>Molecular Cell</source><volume>79</volume><fpage>390</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.06.018</pub-id><pub-id pub-id-type="pmid">32619402</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheetz</surname><given-names>JB</given-names></name><name><surname>Lemmon</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Looking lively: emerging principles of pseudokinase signaling</article-title><source>Trends in Biochemical Sciences</source><volume>47</volume><fpage>875</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2022.04.011</pub-id><pub-id pub-id-type="pmid">35585008</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiu</surname><given-names>SH</given-names></name><name><surname>Bleecker</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Receptor-like kinases from <italic>Arabidopsis</italic> form a monophyletic gene family related to animal receptor kinases</article-title><source>PNAS</source><volume>98</volume><fpage>10763</fpage><lpage>10768</lpage><pub-id pub-id-type="doi">10.1073/pnas.181141598</pub-id><pub-id pub-id-type="pmid">11526204</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiu</surname><given-names>SH</given-names></name><name><surname>Bleecker</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Expansion of the receptor-like kinase/Pelle gene family and receptor-like proteins in <italic>Arabidopsis</italic></article-title><source>Plant Physiology</source><volume>132</volume><fpage>530</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1104/pp.103.021964</pub-id><pub-id pub-id-type="pmid">12805585</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Kornev</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Protein kinases: evolution of dynamic regulatory proteins</article-title><source>Trends in Biochemical Sciences</source><volume>36</volume><fpage>65</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2010.09.006</pub-id><pub-id pub-id-type="pmid">20971646</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Seitz</surname><given-names>K</given-names></name><name><surname>Baer</surname><given-names>J</given-names></name><name><surname>Bennewitz</surname><given-names>S</given-names></name><name><surname>Mooney</surname><given-names>BP</given-names></name><name><surname>Walker</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Analysis of phosphorylation of the receptor-like protein kinase haesa during arabidopsis floral abscission</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0147203</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0147203</pub-id><pub-id pub-id-type="pmid">26784444</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trifinopoulos</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>LT</given-names></name><name><surname>von Haeseler</surname><given-names>A</given-names></name><name><surname>Minh</surname><given-names>BQ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>W-IQ-TREE: a fast online phylogenetic tool for maximum likelihood analysis</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W232</fpage><lpage>W235</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw256</pub-id><pub-id pub-id-type="pmid">27084950</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trusov</surname><given-names>Y</given-names></name><name><surname>Botella</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Plant g-proteins come of age: breaking the bond with animal models</article-title><source>Frontiers in Chemistry</source><volume>4</volume><elocation-id>24</elocation-id><pub-id pub-id-type="doi">10.3389/fchem.2016.00024</pub-id><pub-id pub-id-type="pmid">27252940</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsigelny</surname><given-names>I</given-names></name><name><surname>Greenberg</surname><given-names>JP</given-names></name><name><surname>Cox</surname><given-names>S</given-names></name><name><surname>Nichols</surname><given-names>WL</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Ten Eyck</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>600 ps molecular dynamics reveals stable substructures and flexible hinge points in cAMP dependent protein kinase</article-title><source>Biopolymers</source><volume>50</volume><fpage>513</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0282(19991015)50:5&lt;513::AID-BIP5&gt;3.0.CO;2-I</pub-id><pub-id pub-id-type="pmid">10479734</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Goshe</surname><given-names>MB</given-names></name><name><surname>Soderblom</surname><given-names>EJ</given-names></name><name><surname>Phinney</surname><given-names>BS</given-names></name><name><surname>Kuchar</surname><given-names>JA</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Asami</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Huber</surname><given-names>SC</given-names></name><name><surname>Clouse</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Identification and functional analysis of in vivo phosphorylation sites of the <italic>Arabidopsis</italic> brassinosteroid-insensitive1 receptor kinase</article-title><source>The Plant Cell</source><volume>17</volume><fpage>1685</fpage><lpage>1703</lpage><pub-id pub-id-type="doi">10.1105/tpc.105.031393</pub-id><pub-id pub-id-type="pmid">15894717</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kota</surname><given-names>U</given-names></name><name><surname>He</surname><given-names>K</given-names></name><name><surname>Blackburn</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Goshe</surname><given-names>MB</given-names></name><name><surname>Huber</surname><given-names>SC</given-names></name><name><surname>Clouse</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Sequential transphosphorylation of the BRI1/BAK1 receptor kinase complex impacts early events in brassinosteroid signaling</article-title><source>Developmental Cell</source><volume>15</volume><fpage>220</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2008.06.011</pub-id><pub-id pub-id-type="pmid">18694562</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Lou</surname><given-names>Z</given-names></name><name><surname>Shui</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Assessment of BAK1 activity in different plant receptor-like kinase complexes by quantitative profiling of phosphorylation patterns</article-title><source>Journal of Proteomics</source><volume>108</volume><fpage>484</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1016/j.jprot.2014.06.009</pub-id><pub-id pub-id-type="pmid">24953020</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>E</given-names></name><name><surname>Engler</surname><given-names>C</given-names></name><name><surname>Gruetzner</surname><given-names>R</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name><name><surname>Marillonnet</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A modular cloning system for standardized assembly of multigene constructs</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e16765</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0016765</pub-id><pub-id pub-id-type="pmid">21364738</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wernimont</surname><given-names>AK</given-names></name><name><surname>Artz</surname><given-names>JD</given-names></name><name><surname>Finerty</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>YH</given-names></name><name><surname>Amani</surname><given-names>M</given-names></name><name><surname>Allali-Hassani</surname><given-names>A</given-names></name><name><surname>Senisterra</surname><given-names>G</given-names></name><name><surname>Vedadi</surname><given-names>M</given-names></name><name><surname>Tempel</surname><given-names>W</given-names></name><name><surname>Mackenzie</surname><given-names>F</given-names></name><name><surname>Chau</surname><given-names>I</given-names></name><name><surname>Lourido</surname><given-names>S</given-names></name><name><surname>Sibley</surname><given-names>LD</given-names></name><name><surname>Hui</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>17</volume><fpage>596</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1795</pub-id><pub-id pub-id-type="pmid">20436473</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Jonniya</surname><given-names>NA</given-names></name><name><surname>Hirakis</surname><given-names>SP</given-names></name><name><surname>Olivieri</surname><given-names>C</given-names></name><name><surname>Veglia</surname><given-names>G</given-names></name><name><surname>Kornev</surname><given-names>AP</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Protein kinase structure and dynamics: role of the αc-β4 loop</article-title><source>Molecular Biology</source><volume>01</volume><elocation-id>e5822</elocation-id><pub-id pub-id-type="doi">10.1101/2023.08.31.555822</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>DK</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Lam</surname><given-names>TTY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ggtree: an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data</article-title><source>Methods in Ecology and Evolution</source><volume>8</volume><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1111/2041-210X.12628</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gureasko</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>K</given-names></name><name><surname>Cole</surname><given-names>PA</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor</article-title><source>Cell</source><volume>125</volume><fpage>1137</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.05.013</pub-id><pub-id pub-id-type="pmid">16777603</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zipfel</surname><given-names>C</given-names></name><name><surname>Kunze</surname><given-names>G</given-names></name><name><surname>Chinchilla</surname><given-names>D</given-names></name><name><surname>Caniard</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>JDG</given-names></name><name><surname>Boller</surname><given-names>T</given-names></name><name><surname>Felix</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Perception of the bacterial PAMP EF-Tu by the receptor EFR restricts agrobacterium-mediated transformation</article-title><source>Cell</source><volume>125</volume><fpage>749</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.03.037</pub-id><pub-id pub-id-type="pmid">16713565</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">Col-0</td><td align="left" valign="bottom">ther</td><td align="left" valign="bottom"/><td align="left" valign="bottom">wild-type ecotype</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Nicotiana benthamiana</italic>)</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">Lab stock</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Wild-type strain</td></tr><tr><td align="left" valign="bottom">strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">BL21(DE3) pLPP</td><td align="left" valign="bottom">Amid Biosciences</td><td align="left" valign="bottom">Cat#: BLPP-201</td><td align="left" valign="bottom">Co-expression of<break/> lambda phosphatase</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">BL21(DE3)-V2R-pACYC LamP</td><td align="left" valign="bottom">PMID: 20436473</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Co-expression of <break/>lambda phosphatase</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Agrobacterium tumefaciens</italic>)</td><td align="left" valign="bottom">GV3101</td><td align="left" valign="bottom">Lab stock</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom"><italic>efr-1</italic></td><td align="left" valign="bottom">PMID: 16713565</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">EFR-GFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and <break/>methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">F761H#2</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and<break/> methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">F761H#7</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and<break/> methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">Y836F#1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials <break/>and methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">Y836F#4</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and <break/>methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">F761H/Y836F#1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and <break/>methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">F761H/Y836F#5</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and <break/>methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">SSAA#2</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials <break/>and methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">SSAA#7</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials <break/>and methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">F761H/SSAA#2</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials <break/>and methods</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Arabidopsis thaliana</italic>)</td><td align="left" valign="bottom">F761H/SSAA#7</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials <break/>and methods</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGAAGACaaAATGA<break/>AGCTGTCCTTTTCACTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR Y836F-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">ggagtTtctgcacgtt<break/>cattgtcatgaccctgta</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR SSAA-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">Gtttgctgctgctggt<break/>gtcagaggcaccat</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR F761H-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">acgatgtcgtatacccttgt<break/>gggtttcacattccgccata</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR F761M-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">tacgatgtcgtatacccttc<break/>atggtttcacattccgccata</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR V845F-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">gcttaatatcacagtgagc<break/>gaaagggtcatgacaatgaacgtg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR L743F-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">gctttaggaggttgaaaac<break/>tttaaccgcgacgagttta</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR L873E-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">ctcagGAGctctataaata<break/>cgatcgagaatcctttcta</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR dNLLKH-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">taaagttttgggagcgacga<break/>aaagctttatggcggaatgtg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR D849N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cactgtAatattaagcca<break/>agcaacattcttctagacgat</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGAAGACaaAATGGA<break/>ACGAAGATTAATGATCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1 Y403F-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cttgcgtttttacatgat<break/>cattgcgacccaaaga</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1 I338H-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">gagatgCAtagtatggcg<break/>gttcacagaaacttgct</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1 D416N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">catcgaAatgtgaaagctg<break/>caaatattttgttggatgaag</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFRprom-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGgtctctTACGCGTCTC<break/>aGTAGatctagacgat<break/>taagtaattgagca</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1prom-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGgtctctTACGCGTCTCa<break/>CCTAtgtcgtgaaaagggcac</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa2_Tmicd-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCgAAGGTT<break/>CTTCTACCGGTTCTGTTAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa3_Tmicd-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCgAAGG<break/>TTGCGATTGGGGTCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa4_Tmicd-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCgAAGATAA<break/>TCACCATTTGTGTCAGTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa5_Tmicd-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCgAAGGTT<break/>GTGATTGGAGTTAGCGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa6_Tmicd-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCgAAGGTTG<break/>CAATTTTAGTAAGCATAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FLS2_Tmicd-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCgAAGGTCA<break/>TCCTGATTATTCTTGGATCA<break/>GCCGCGGCaCTTCTTCTTGTCCTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">AlXIIa_D850N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAGTa<break/>ATATTAAGCCAAGCAACG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BrXIIa_D846N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAGTaA<break/>TCTTAAGCCAAGCAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GmXIIa_D829N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAGTaATA<break/>TTAAGCCAAGCAACATT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PtXIIa_D848N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAGT<break/>aatctgaagccaagcaa</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">SlXIIa_D883N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAGTaATAT<break/>AAAACCACAGAACATTCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa2_D803N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAGTaATC<break/>TCAAACCGAGCAATATCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa3_D838N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCACaATCT<break/>TAAGCCAAGCAACATACT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa4_D856N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer<break/></td><td align="left" valign="bottom">atcgGCTCTTCAGTaATATT<break/>AAGCCAAGCAATATTCTACTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa5_D839N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAGCaA<break/>TCTTAAGCCAAGCAACGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa6_D840N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAGCaATC<break/>TCAAGCCAAGCAACG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FLS2icd_D997N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAGTaATC<break/>TGAAGCCAGCTAATATACT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FLS2_D997N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GTTCATTGTaATCTGAAGC<break/>CAGCTAATATACTCCTTGACA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_ecto-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGGTCTCaAATGAAG<break/>CTGTCCTTTTCACTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_SapIdom-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GTTATGAgGAGCTTCAT<break/>AGTGCAACAAGTCGCTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_Esp3Idom-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">TTCCCGTgTCTTTCGGG<break/>AAGCTTTTGAACTTGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">ccdB cassette-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atgcGGTCTCAGAAGgGAAG<break/>AGCAAAGCTGAACGA<break/>GAAACGTAAAAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">pET28_lin-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">tgagatccggctgctaa</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">pETGG cloning cassette-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">AGAAGGAGATATACCAATGAGAGACCAAAGCTGAA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">P641-BsaI_mut1-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">agagacCaaagctgaacga<break/>gaaacgtaaaatgatataaata</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">P641-BsaI_mut2-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">gccagtGgtctcttc<break/>tggtcgtgactggg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="char" char="hyphen" valign="bottom">6xHis-FKBP-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtTACGGGTCT<break/>CaAATGggcagcagccatcatcatc<break/>atcatcacagcagcggcGGA<break/>GTGCAGGTGGAAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="char" char="hyphen" valign="bottom">6xHis-FRB-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtTACGGGTCTCaA<break/>ATGggcagcagccatcatcatcatcatc<break/>acagcagcggcATCCT<break/>CTGGCATGAGATGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_icd (stop)-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtTACGGGTCT<break/>CaAGGTaagaggaaaaag<break/>aaaaacaatgcc</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_icd (no stop)-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtTACGGGTCTCa<break/>AGGTaagaggaaa<break/>aagaaaaacaatgcc</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1_icd (stop)-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtTACGGGTCTC<break/>aAGGTgcttggtggcgaagg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FLS2_icd (no stop)-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtTACGGGTCTCaAG<break/>GTACCTGTTGCAAGAAA<break/>AAAGAAAAAAAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BRI1_icd (no stop)-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGGTCTCaAGGT<break/>GGTAGAGAGATGA<break/>GGAAGAGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BRI1icd_D1009N-f</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGGTCTCaAaACATG<break/>AAATCCAGTAATGTGTTGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cgatGAAGACttCGAAcc<break/>CATAGTATGCATGTCCG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR Y836F-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">gtgcagaAactccaaagc<break/>tgaagccacatctat</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR SSAA-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">gcagcagcaaactggttt<break/>agaaaggattctcgatcg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR F761H-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">tatggcggaatgtgaaacc<break/>cacaagggtatacgacatcgt</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR F761M-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">tatggcggaatgtgaaaccat<break/>gaagggtatacgacatcgta</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR V845F-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cacgttcattgtcatgaccctt<break/>tcgctcactgtgatattaagc</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR L743F-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">taaactcgtcgcggttaaa<break/>gttttcaacctcctaaagc</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR L873E-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">tatagagCTCctgagcca<break/>aaccaaagtcactaacatg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR dNLLKH-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">tcgtcgctcccaaaactttaa<break/>ccgcgacgagtttattct</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR D849N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">ggcttaatatTacagtgag<break/>ctacagggtcatgaca</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cgatGAAGACttAAGCc<break/>cTTATCTTGGACCCGAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1 Y403F-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">catgtaaaaacgca<break/>agccctcttgcagatccca</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1 I338H-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">ccatactaTGcatctca<break/>acctctgtctggaactgc</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1 D416N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">ctttcacatTtcgatgaata<break/>atctttgggtcgcaatg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFRprom-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGgtctctCAGACGTCTC<break/>aCATTgtcgattataaaaa<break/>gataaaagaaaggtt</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1prom-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGgtctctCAGACGTCT<break/>CaCATTtttatcctcaagag<break/>attaaaaacaaac</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa2_Tmicd-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cgatGCTCTTCtCGAAccT<break/>GAACTAGCTTCTCCTTGTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa3_Tmicd-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cgatGCTCTTCtCGAAccA<break/>CGTCTGGCTGTTCTCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa4_Tmicd-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cgatGCTCTTCtCGAAccAG<break/>TCTCCTCGTCTCTGAAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa5_Tmicd-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cgatGCTCTTCtCGAAccACGCC<break/>AAGTCGTTCTACTGGCTT<break/>TAAAGAACCTCTCTCTGAT<break/>TGAGATCAACTCCTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa6_Tmicd-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cgatGCTCTTCtCGAAccAC<break/>GTCTAGGTGTTCTTCTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FLS2_Tmicd-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cgatGCTCTTCtCGAAccA<break/>ACTTCTCGATCCTCGTTAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">AlXIIa_D850N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtACA<break/>GTGAGCTACAGGGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BrXIIa_D846N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtACAG<break/>TGAGCTATTTGGTCAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GmXIIa_D829N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtACA<break/>GTGAACTACGGCCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PtXIIa_D848N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtACa<break/>atgaatgatgggcatg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">SlXIIa_D883N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtACA<break/>GTGAATCATGGGTGTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa2_D803N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtACAGT<break/>GAACAACTTTTACAGGTGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa3_D838N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCATtGCAA<break/>TGAGCTATAGGCTCATGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa4_D856N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtACA<break/>GTGGGCTATAGGGTTGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa5_D839N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtGCAA<break/>TGAGCTATAGGTTCATGACA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">XIIa6_D840N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtGCAAT<break/>GAGCTATAGGCTCATGAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FLS2icd_D997N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGCTCTTCAtACAA<break/>TGAACGATGGGAAAACC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FLS2_D997N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">CTTCAGATtACAATGAAC<break/>GATGGGAAAACCATATCCAGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_ecto-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGGTCTCacTTCT<break/>TTCTAACTGACAGAGGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_SapIdom-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">TGAAGCTCcTCATAACT<break/>TACCTTCTCATGGAACATCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_Esp3Idom-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">GAAAGAcACGGGAAGT<break/>TCTCCACTCAACATATTTGTTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">ccdB cassette-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">tacgGGTCTCACGAAGA<break/>AGAGCactggctgtgtataaggga</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">pET28_lin-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">ggtatatctccttct<break/>taaagttaaaca</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">pETGG cloning cassette-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">AGCAGCCGGATCTCAAAGCAGAGACCACTGGC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">P641-BsaI_mut1-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">cagctttGgtctctcg<break/>tacggcctcctgt</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">P641-BsaI_mut2-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">agagacCactggctgtg<break/>tataagggagcctga</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="char" char="hyphen" valign="bottom">6xHis-FKBP-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtCAGAGGTC<break/>TCaACCTGAGCCGCTTTCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="char" char="hyphen" valign="bottom">6xHis-FRB-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtCAGAGGTCT<break/>CaACCTGAGCCGCTCTTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_icd (stop)-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtCAGAGGTCTC<break/>aAAGCttacatagtatgcatgtccgtatt</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">EFR_icd (no stop)-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtCAGAGGTCTC<break/>aAAGCttacatagtatgcatgtccgtatt</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BAK1_icd (stop)-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtCAGAGGTC<break/>TCaAAGCttatcttggacccgaggg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">FLS2_icd (no stop)-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgCGTCTCtCAGAGGTCTCaC<break/>GAAccAACTTCTCGATCCTCGTTACG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BRI1_icd (no stop)-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGGTCTCaCGAAccTAA<break/>TTTTCCTTCAGGAACTTCTTTTATA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">BRI1icd_D1009N-r</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">atcgGGTCTCaGTtTCTGT<break/>GGATGATATGCGGAC</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">GFP-HRP; mouse monoclonal</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat#: sc-9996</td><td align="left" valign="bottom">Dilution: 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BAK1; rabbit polyclonal</td><td align="left" valign="bottom">PMID: 21693696</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Dilution: 1:10000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BAK1 pS612; rabbit polyclonal</td><td align="left" valign="bottom">PMID: 30177827</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Dilution: 1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FKBP12; mouse monoclonal</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat#: sc-133067</td><td align="left" valign="bottom">Dilution: 1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">p44/42; rabbit polyclonal</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#: 9101</td><td align="left" valign="bottom">Dilution: 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit-HRP; goat polyclonal</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat#: A0545</td><td align="left" valign="bottom">Dilution: 1:10000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse-HRP; goat polyclonal</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat#: A0168</td><td align="left" valign="bottom">Dilution: 1:5000</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-EFRprom(BsaI)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">35 S_omegaEnhancer</td><td align="left" valign="bottom">PMID: 21364738</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICH41258-nMyr-FKBP</td><td align="left" valign="bottom">PMID: 33964457</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICH41258-nMyr-FRB</td><td align="left" valign="bottom">PMID: 33964457</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01003-GFP</td><td align="left" valign="bottom">PMID: 21364738</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01003-mEGFP</td><td align="left" valign="bottom">Mark Youles, TSL</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">HSP18t</td><td align="left" valign="bottom">Mark Youles, TSL</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-6xHis-FKBP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-6xHis-FRB</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR Y836F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR SSAA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR F761H</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR F761M</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR dNLLKH</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR L743F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR L873E</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR F761H Y836F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR F761M Y836F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR dNLLKH Y836F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR L743F Y836F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR L873E Y836F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR D849N</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR F761H D849N</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR F761H SSAA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL01005-EFR F761M SSAA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICH41308-BAK1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and MethodsSee Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICH41308-BAK1 Y403F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and MethodsSee Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955</td><td align="left" valign="bottom">PMID: 21364738</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR Y836F-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR SSAA-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR F761H-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR F761M-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR dNLLKH-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR L743F-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR L873E-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR F761H Y836F-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR F761M Y836F-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR dNLLKH Y836F-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR L743F Y836F -GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR Y836F L873E-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR F761H SSAA-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-pEFR::EFR F761M SSAA-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641</td><td align="left" valign="bottom">PMID: 31300661</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-EFR_icd</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-EFR F761H_icd</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-EFR D849N_icd</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-EFR F761H D849N_icd</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-BAK1_icd</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-BAK1 Y403F_icd</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p641-BAK1 D416N_icd</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-ccdB-GFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa2icd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa2 D803N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa3icd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa3 D838N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa4icd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa4 D856N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa5icd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa5 D839N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa6icd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XIIa6 D840N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-FLS2icd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-FLS2 D997N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-EFRicd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-EFR D849N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XA21icd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-XA21 D803N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-Aralyicd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-Araly D850N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-Brapaicd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-Brapa D846N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-Solycicd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-Solyc D883N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-Poptricd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-Poptr D848N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-Glymaicd-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL86955-35S::EFRecto-GlymaD829N-mEGFP::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG-6xHis-FKBP-EFRicd-mEGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG-6xHis-FKBP-EFRicd D849N-mEGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG-6xHis-FKBP-BRI1-mEGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG-6xHis-FKBP-BRI1 D1009N-mEGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG-6xHis-FKBP-FLS2-mEGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG-6xHis-FKBP-FLS D997N-mEGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG-6xHis-FKBP-XIIa5-mEGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG-6xHis-FKBP-XIIa5 D839N-mEGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pETGG-6xHis-FRB-BAK1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pET28a(+)–6xHis-BIK1 D202N</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pC1a1-35S::FRB-BAK1_icd::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pC1a1-35S::FRB-BAK1 Y403F_icd::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pC1a1-35S::FRB-BAK1 D416N_icd::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pC1a2-35S::FKBP-EFR_icd::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pC1a2-35S::FKBP-EFR F761H_icd::HSP18t</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL4723</td><td align="left" valign="bottom">PMID: 21364738</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL4723-FRB-BAK1-FKBP-EFR</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL4723-FRB-BAK1 D416N-FKBP-EFR</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL4723-FRB-BAK1-FKBP-EFR F761H</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL4723-FRB-BAK1 D416N-FKBP-EFR F761H</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL4723-FRB-BAK1 Y403F-FKBP-EFR</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pICSL4723-FRB-BAK1 Y403F-FKBP-EFR F761H</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and methods</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92110.4.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Goethe University</institution><country>Germany</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This manuscript reports <bold>important</bold> in vitro biochemical and in planta experiments to study the receptor activation mechanism of plant membrane receptor kinase complexes through the non-catalytic function of an active protein kinase. Several lines of evidence <bold>convincingly</bold> show that one such receptor kinase with pseudokinase-like function, the immune receptor EFR achieves an active conformation following phosphorylation by a co-receptor kinase, and then in turn activates the co-receptor kinase allosterically to enable it to phosphorylate down-stream signaling components. This manuscript will be of interest to scientists focusing on cell signalling and allosteric regulation.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92110.4.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary</p><p>The authors use an elegant but somewhat artificial heterodimerisation approach to activate the isolated cytoplasmic domains of different receptor kinases (RKs) including the receptor kinase BRI1 and EFR. The developmental RK BRI1 is known to be activated by the co-receptor BAK1. Active BRI1 is then able to phosphorylate downstream substrates. The immune receptor EFR is also an active protein kinase also activated by the co-receptor BAK1. EFR however appears to have little or no kinase activity but seems to use an allosteric mechanism to in turn enable BAK1 to phosphorylate the substrate kinase BIK1. EFR tyrosine phosphorylation by BAK1 appears to trigger a conformational change in EFR, activating the receptor. Likewise, kinase activating mutations can cause similar conformational transitions in EFR and also in BAK1 in vitro and in planta.</p><p>Strengths:</p><p>I particularly liked The HDX experiments coupled with mutational analysis (Fig. 2) and the design and testing of the kinase activating mutations (Fig. 3), as they provide novel mechanistic insights into the activation mechanisms of EFR and of BAK1. These findings are nicely extended by the large-scale identification of EFR-related RKs from different species with potentially similar activation mechanisms (Fig. 5).</p><p>Overall this is an interesting study that aims to advance our understanding of the activation mechanisms of different plant receptor kinases with important functions in plant immunity.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92110.4.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Transmembrane signaling in plants is crucial for homeostasis. In this study, the authors set out to understand to what extent catalytic activity in the EFR tyrosine kinase is required in order to transmit a signal. This work was driven by mounting data that suggest many eukaryotic kinases do not rely on catalysis for signal transduction, relying instead on conformational switching to relay information. The crucial findings reported here involve the realisation that a kinase-inactive EFR can still activate (ie lead to downstream phosphorylation) of its partner protein BAK1. Using a convincing set of biochemical, mass spectrometric (HD-exchange) and in vivo assays, the team suggests a model in which EFR is likely phosphorylated in the canonical activation segment (where two Ser residues are present), which is sufficient to generate a conformation that can activate BAK1 through dimersation. A model is put forward involving C-helix positioning in BAK1, and the model is extended to other 'non-RD' kinases in Arabidopsis kinases that likely do not require kinase activity for signaling.</p><p>Strengths:</p><p>The work uses logical and well-controlled approaches throughout, and is clear and convincing in most areas, linking data from IPs, kinase assays (including clear 32P-based biochemistry), HD-MX data (from non-phosphorylated EFR) structural biology, oxidative burst data and infectivity assays. Repetitions and statistical analysis all appear appropriate.</p><p>Overall, the work builds a convincing story and the discussion does a clear job of explaining the potential impact of these findings (and perhaps an explanation of why so many Arabidopsis kinases are 'pseudokinases', including XPS1 and XIIa6, where this is shown explicitly).</p><p>Impact:</p><p>The work is an important new step in the huge amount of follow-up work needed to examine how kinases and pseudokinases 'talk' to each other in (especially) the plant kingdom, where significant genetic expansions have occurred. The broader impact is that we might understand better how to manipulate signaling for the benefit of plants and mankind; as the authors suggest, their study is a natural progression both of their own work and the kingdom-wide study of the Kannan group.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92110.4.sa3</article-id><title-group><article-title>Reviewer #3 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The study presents strong evidence for allosteric activation of plant receptor kinases, which enhances our understanding of the non-catalytic mechanisms employed by this large family of receptors.</p><p>Plant receptor kinases (RKs) play a critical role in transducing extracellular signals. The activation of RKs involves homo- or heterodimerization of the RKs, and it is believed that mutual phosphorylation of their intracellular kinase domains initiates downstream signaling. However, this model faces a challenge in cases where the kinase domain exhibits pseudokinase characteristics. In their recent study, Mühlenbeck et al. reveal the non-catalytic activation mechanisms of the EFR-BAK1 complex in plant receptor kinase signaling. Specifically, they aimed to determine that the EFR kinase domain activates BAK1 not through its kinase activity, but rather by utilizing a &quot;conformational toggle&quot; mechanism to enter an active-like state, enabling allosteric trans-activation of BAK1. The study sought to elucidate the structural elements and mutations of EFR that affect this conformational switch, as well as explore the implications for immune signaling in plants. To investigate the activation mechanisms of the EFR-BAK1 complex, the research team employed a combination of mutational analysis, structural studies, and hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis. For instance, through HDX-MS analysis, Mühlenbeck et al. discovered that the EFR (Y836F) mutation impairs the accessibility of the active-like conformation. On the other hand, they identified the EFR (F761H) mutation as a potent intragenic suppressor capable of stabilizing the active-like conformation, highlighting the pivotal role of allosteric regulation in BAK1 kinase activation. The data obtained from this methodology strengthens their major conclusion. Moreover, the researchers propose that the allosteric activation mechanism may extend beyond the EFR-BAK1 complex, as it may also be partially conserved in the Arabidopsis LRR-RK XIIa kinases. This suggests a broader role for non-catalytic mechanisms in plant RK signaling.</p><p>The allosteric activation mechanism was demonstrated for receptor tyrosine kinases (RTKs) many years ago. A similar mechanism has been suggested for the activation of plant RKs, but experimental evidence for this conclusion is lacking. Data in this study represent a significant advancement in our understanding of non-catalytic mechanisms in plant RK signaling. By shedding light on the allosteric regulation of BAK1, the study provides a new paradigm for future research in this area.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92110.4.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mühlenbeck</surname><given-names>Henning</given-names></name><role specific-use="author">Author</role><aff><institution>University of Zurich</institution><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Tsutsui</surname><given-names>Yuko</given-names></name><role specific-use="author">Author</role><aff><institution>Yale University</institution><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Lemmon</surname><given-names>Mark A</given-names></name><role specific-use="author">Author</role><aff><institution>Yale University</institution><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Bender</surname><given-names>Kyle W</given-names></name><role specific-use="author">Author</role><aff><institution>University of Zurich</institution><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff></contrib><contrib contrib-type="author"><name><surname>Zipfel</surname><given-names>Cyril</given-names></name><role specific-use="author">Author</role><aff><institution>University of Zurich</institution><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews.</p><disp-quote content-type="editor-comment"><p><bold>eLife assessment</bold></p><p>This manuscript reports important in vitro biochemical and in planta experiments to study the receptor activation mechanism of plant membrane receptor kinase complexes with non-catalytic intracellular kinase domains. Several lines of evidence convincingly show that one such putative pseudokinase, the immune receptor EFR achieves an active conformation following phosphorylation by a co-receptor kinase, and then in turn activates the co-receptor kinase allosterically to enable it to phosphorylate down-stream signaling components. This manuscript will be of interest to scientists focusing on cell signalling and allosteric regulation.</p></disp-quote><p>We wish to clarify that EFR is itself, not a pseudokinase. We could show in previous work (Bender et al., 2021; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.2108242118">https://doi.org/10.1073/pnas.2108242118</ext-link> ) that EFR has catalytic activity in vitro. This catalytic activity is, however, not required for elf18-induced immune signaling in planta.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary</p><p>The authors use an elegant but somewhat artificial heterodimerisation approach to activate the isolated cytoplasmic domains of different receptor kinases (RKs) including the receptor kinase BRI1 and EFR. The developmental RK BRI1 is known to be activated by the co-receptor BAK1. Active BRI1 is then able to phosphorylate downstream substrates. The immune receptor EFR is also an active protein kinase also activated by the co-receptor BAK1. EFR however appears to have little or no kinase activity but seems to use an allosteric mechanism to in turn enable BAK1 to phosphorylate the substrate kinase BIK1. EFR tyrosine phosphorylation by BAK1 appears to trigger a conformational change in EFR, activating the receptor. Likewise, kinase activating mutations can cause similar conformational transitions in EFR and also in BAK1 in vitro and in planta.</p></disp-quote><p>We wish to clarify that we make no strong link between tyrosine phosphorylation and the conformational change leading to activation of the complex. Rather, the HDX-MS data demonstrate the structural importance of Tyr836 for the activation mechanism. At present, we do not know how phosphorylation of the residue would affect the activation process.</p><disp-quote content-type="editor-comment"><p>Strengths:</p><p>I particularly liked The HDX experiments coupled with mutational analysis (Fig. 2) and the design and testing of the kinase activating mutations (Fig. 3), as they provide novel mechanistic insights into the activation mechanisms of EFR and of BAK1. These findings are nicely extended by the large-scale identification of EFR-related RKs from different species with potentially similar activation mechanisms (Fig. 5).</p><p>Weaknesses:</p><p>In my opinion, there are currently two major issues with the present manuscript. (1) The authors have previously reported that the EFR kinase activity is dispensible for immune signaling (<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34531323/">https://pubmed.ncbi.nlm.nih.gov/34531323/</ext-link>) but the wild-type EFR receptor still leads to a much better phosphorylation of the BIK1 substrate when compared to the kinase inactive D849N mutant protein (Fig. 1). (2) How the active-like conformation of EFR is in turn activating BAK1 is poorly characterized, but appears to be the main step in the activation of the receptor complex. Extending the HDX analyses to resting and Rap-activated receptor complexes could be a first step to address this question, but these HDX studies were not carried out due to technical limitations.</p><p>Overall this is an interesting study that aims to advance our understanding of the activation mechanisms of different plant receptor kinases with important functions in plant immunity.</p><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>Transmembrane signaling in plants is crucial for homeostasis. In this study, the authors set out to understand to what extent catalytic activity in the EFR tyrosine kinase is required in order to transmit a signal. This work was driven by mounting data that suggest many eukaryotic kinases do not rely on catalysis for signal transduction, relying instead on conformational switching to relay information. The crucial findings reported here involve the realisation that a kinase-inactive EFR can still activate (ie lead to downstream phosphorylation) of its partner protein BAK1. Using a convincing set of biochemical, mass spectrometric (HD-exchange) and in vivo assays, the team suggest a model in which EFR is likely phosphorylated in the canonical activation segment (where two Ser residues are present), which is sufficient to generate a conformation that can activate BAK1 through dimersation. A model is put forward involving C-helix positioning in BAK1, and the model extended to other 'non-RD' kinases in Arabidopsis kinases that likely do not require kinase activity for signaling.</p></disp-quote><p>We prefer not to describe EFR as a tyrosine kinase. It may be the case that EFR can function under certain conditions as a dual-specificity protein kinase, but this has never been demonstrated experimentally. We therefore describe EFR as a Ser/Thr protein kinase, since it is known that the isolated cytoplasmic domain can phosphorylate on Ser and Thr residues (Wang et al., 2014; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jprot.2014.06.009">https://doi.org/10.1016/j.jprot.2014.06.009</ext-link>).</p><disp-quote content-type="editor-comment"><p>Strengths:</p><p>The work uses logical and well-controlled approaches throughout, and is clear and convincing in most areas, linking data from IPs, kinase assays (including clear 32P-based biochemistry), HD-MX data (from non-phosphorylated EFR) structural biology, oxidative burst data and infectivity assays. Repetitions and statistical analysis all appear appropriate.</p><p>Overall, the work builds a convincing story and the discussion does a clear job of explaining the potential impact of these findings (and perhaps an explanation of why so many Arabidopsis kinases are 'pseudokinases', including XPS1 and XIIa6, where this is shown explicitly).</p><p>Weaknesses:</p><p>No major weaknesses are noted from reviewing the data and the paper follows a logical course built on solid foundations; the use of Tables to explain various experimental data pertinent to the reported studies is appreciated.</p><p>(1) The use of a, b,c, d in Figures 2C and 3C etc is confusing to this referee, and is now addressed in the latest version</p><p>(2) The debate about kinase v pseudokinases is well over a decade old. For non-experts, the kinase alignments/issues raised are in PMID: 23863165 and might prove useful if cited.</p></disp-quote><p>We have cited the suggested reference in the second paragraph of the discussion.</p><disp-quote content-type="editor-comment"><p>(3) Early on in the paper, the concept of kinases and pseudokinases related to R-spine (and extended R-spine) stability and regulation really needs to be more adequately introduced to explain what comes next; e.g. some of the key work in this area for RAF and Tyr kinases where mutual F-helix Phe amino acid changes are evaluated (conceptually similar to this study of the E-helix Tyr to Phe changes in EFR) should be cited (PMID: 17095602, 24567368 and 26925779).</p></disp-quote><p>As an alternative, we have amended the text in several places to focus on conformational toggling between active/inactive states rather than R-spine stability. We think that this keeps the message of our manuscript focused. We hope that the reviewer finds this acceptable.</p><disp-quote content-type="editor-comment"><p>(4) In my version, some of the experimental text is also currently in the wrong order (and no page numbers, so hard for me to state exactly where in the manuscript); However, I am certain that Figure 2C is mentioned in the text when the data are actually shown in Figure 3C for the EFR-SSAA protein.</p></disp-quote><p>Indeed, some references to Figure 2 in the text were incorrect. We have corrected these. References in the text to Figure 3 and the data reported therein are correct.</p><disp-quote content-type="editor-comment"><p>(5) Tyr 156 in PKA is not shown in Supplement 1, 2A as suggested in the text; for readers, it will be important to show the alignment of the Tyr residue in other kinases; this has been updated in the second version. Although it is clearly challenging to generate phosphorylated EFR (seemingly through Codon-expansion here?), it appears unlikely that a phosphorylated EFR protein, even semi-pure, couldn't have been assayed to test the idea that the phosphorylation drives/supports downstream signaling. What about a DD or EE mutation, as commonly used (perhaps over-used) in MEK-type studies?</p></disp-quote><p>Our aim with codon expansion was to generate recombinant protein carrying high-stoichiometry phosphorylation at sites which we have previously documented to be required for downstream signaling (Macho <italic>et al</italic>., 2014; Bender <italic>et al</italic>., 2021). We additionally demonstrated previously that a DD mutant of the activation loop sites in EFR does not fully complement the efr-1 mutant (Bender et al., 2021), suggesting that the Asp mutations are not good phospho-mimics in this context. We therefore did not generate DD or EE mutations for in vitro studies.</p><disp-quote content-type="editor-comment"><p>Impact:</p><p>The work is an important new step in the huge amount of follow-up work needed to examine how kinases and pseudokinases 'talk' to each other in (especially) the plant kingdom, where significant genetic expansions have occurred. The broader impact is that we might understand better how to manipulate signaling for the benefit of plants and mankind; as the authors suggest, their study is a natural progression both of their own work, and the kingdom-wide study of the Kannan group.</p><p><bold>Reviewer #3 (Public Review):</bold></p><p>The study presents strong evidence for allosteric activation of plant receptor kinases, which enhances our understanding of the non-catalytic mechanisms employed by this large family of receptors.</p><p>Plant receptor kinases (RKs) play a critical role in transducing extracellular signals. The activation of RKs involves homo- or heterodimerization of the RKs, and it is believed that mutual phosphorylation of their intracellular kinase domains initiates downstream signaling. However, this model faces a challenge in cases where the kinase domain exhibits pseudokinase characteristics. In their recent study, Mühlenbeck et al. reveal the non-catalytic activation mechanisms of the EFR-BAK1 complex in plant receptor kinase signaling. Specifically, they aimed to determine that the EFR kinase domain activates BAK1 not through its kinase activity, but rather by utilizing a &quot;conformational toggle&quot; mechanism to enter an active-like state, enabling allosteric trans-activation of BAK1. The study sought to elucidate the structural elements and mutations of EFR that affect this conformational switch, as well as explore the implications for immune signaling in plants. To investigate the activation mechanisms of the EFR-BAK1 complex, the research team employed a combination of mutational analysis, structural studies, and hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis. For instance, through HDX-MS analysis, Mühlenbeck et al. discovered that the EFR (Y836F) mutation impairs the accessibility of the active-like conformation. On the other hand, they identified the EFR (F761H) mutation as a potent intragenic suppressor capable of stabilizing the active-like conformation, highlighting the pivotal role of allosteric regulation in BAK1 kinase activation. The data obtained from this methodology strengthens their major conclusion. Moreover, the researchers propose that the allosteric activation mechanism may extend beyond the EFR-BAK1 complex, as it may also be partially conserved in the Arabidopsis LRR-RK XIIa kinases. This suggests a broader role for non-catalytic mechanisms in plant RK signaling.</p><p>The allosteric activation mechanism was demonstrated for receptor tyrosine kinases (RTKs) many years ago. A similar mechanism has been suggested for the activation of plant RKs, but experimental evidence for this conclusion is lacking. Data in this study represent a significant advancement in our understanding of non-catalytic mechanisms in plant RK signaling. By shedding light on the allosteric regulation of BAK1, the study provides a new paradigm for future research in this area.</p><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>The authors have considered points 1-5 raised in my initial review and the revised manuscript contains a more balanced discussion and limitation section. No additional experiments have been performed to substantiate the envisioned allosteric activation mechanism of the co-receptor kinase BAK1 by the receptor EFR. I rewrote the public statement accordingly.</p><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>Thanks for responding to my comments.</p><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>The revised manuscript has fully addressed my previous concerns and is now suitable for publication in eLife.</p></disp-quote></body></sub-article></article>